Skip to main content
Erschienen in: Alzheimer's Research & Therapy 1/2015

Open Access 01.12.2015 | Research

Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review

verfasst von: Katrin Jekel, Marinella Damian, Carina Wattmo, Lucrezia Hausner, Roger Bullock, Peter J Connelly, Bruno Dubois, Maria Eriksdotter, Michael Ewers, Elmar Graessel, Milica G Kramberger, Emma Law, Patrizia Mecocci, José L Molinuevo, Louise Nygård, Marcel GM Olde-Rikkert, Jean-Marc Orgogozo, Florence Pasquier, Karine Peres, Eric Salmon, Sietske AM Sikkes, Tomasz Sobow, René Spiegel, Magda Tsolaki, Bengt Winblad, Lutz Frölich

Erschienen in: Alzheimer's Research & Therapy | Ausgabe 1/2015

Abstract

Introduction

There is a growing body of evidence that subtle deficits in instrumental activities of daily living (IADL) may be present in mild cognitive impairment (MCI). However, it is not clear if there are IADL domains that are consistently affected across patients with MCI. In this systematic review, therefore, we aimed to summarize research results regarding the performance of MCI patients in specific IADL (sub)domains compared with persons who are cognitively normal and/or patients with dementia.

Methods

The databases PsycINFO, PubMed and Web of Science were searched for relevant literature in December 2013. Publications from 1999 onward were considered for inclusion. Altogether, 497 articles were retrieved. Reference lists of selected articles were searched for potentially relevant articles. After screening the abstracts of these 497 articles, 37 articles were included in this review.

Results

In 35 studies, IADL deficits (such as problems with medication intake, telephone use, keeping appointments, finding things at home and using everyday technology) were documented in patients with MCI. Financial capacity in patients with MCI was affected in the majority of studies. Effect sizes for group differences between patients with MCI and healthy controls were predominantly moderate to large. Performance-based instruments showed slight advantages (in terms of effect sizes) in detecting group differences in IADL functioning between patients with MCI, patients with Alzheimer’s disease and healthy controls.

Conclusion

IADL requiring higher neuropsychological functioning seem to be most severely affected in patients with MCI. A reliable identification of such deficits is necessary, as patients with MCI with IADL deficits seem to have a higher risk of converting to dementia than patients with MCI without IADL deficits. The use of assessment tools specifically designed and validated for patients with MCI is therefore strongly recommended. Furthermore, the development of performance-based assessment instruments should be intensified, as they allow a valid and reliable assessment of subtle IADL deficits in MCI, even if a proxy is not available. Another important point to consider when designing new scales is the inclusion of technology-associated IADL. Novel instruments for clinical practice should be time-efficient and easy to administer.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KJ conducted the literature search with support from MD, LH and LF and wrote the first draft of the manuscript. MEr, FP and LN added and analyzed literature regarding technology use. PJC, KP, EL and SAMS provided valuable input for restructuring parts of the manuscript. CW, RB, BD, MEw, EG, MGK, PM, JLM, MGMOR, JMO, ES, TS, RS, MT and BW were involved in revising the manuscript. All authors read and approved the final manuscript.
Abkürzungen
AD
Alzheimer’s disease
ADCS-ADL
Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory
ADCS-MCI-ADL-18
18-item Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairment
ADCS-MCI-ADL-24
24-item Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairment
ADL
Activities of daily living
ADL-PI
Activities of Daily Living-Prevention Instrument
am
Amnestic multiple domain
aMCI
Amnestic mild cognitive impairment
as
Amnestic single domain
BADL
Basic activities of daily living
Bayer-ADL
Bayer Activities of Daily Living Scale
CDR
Clinical dementia rating
DAD
Disability Assessment for Dementia
DAD-6
6-item Disability Assessment for Dementia
DAFS
Direct Assessment of Functional Status
DHQ
Driving Habits Questionnaire
DOT
Day-Out Task
EPT
Everyday Problems Test
ETUQ
Everyday Technology Use Questionnaire
FAQ
Functional Activities Questionnaire
FC-ADL
Functional Capacities for Activities of Daily Living
FCI
Financial Capacity Instrument
FC-IADL
Functional Capacities for Instrumental Activities of Daily Living
IADL
Instrumental activities of daily living
4-IADL
4-item Instrumental Activities of Daily Living scale items chosen from Lawton and Brody
9-IADL
9-item Instrumental Activities of Daily Living scale
ICC
Intraclass correlation coefficient
IQCODE
Informant Questionnaire on Cognitive Decline in the Elderly
KI-IADL
Knowledgeable Informant report about Instrumental Activities of Daily Living
L&B IADL
Lawton and Brody’s Instrumental Activities of Daily Living
MCI
Mild cognitive impairment
md
Multiple domain
META
Management of Everyday Technology Assessment
MMSE
Mini Mental State Examination
nam
Nonamnestic multiple domain
naMCI
Nonamnestic mild cognitive impairment
nas
Nonamnestic single domain
NAT
Naturalistic action task
NC
Normal control
NIA-AA
National Institute on Aging and Alzheimer’s Association
ns
nonsignificant
ROIL
Record of Independent Living
sd
Single domain
SD
Standard deviation
S-IADL
Seoul-Instrumental Activities of Daily Living
SIB-R
Scales of Independent Behavior–Revised
SR-IADL
Self-report Instrumental Activities of Daily Living
TADL-Q
Technology–Activities of Daily Living Questionnaire
TFLS
Texas Functional Living Scale
TIADL
Timed Instrumental Activities of Daily Living
UAB-DA
University of Alabama at Birmingham Driving Assessment
UCSD-UPSA
University of California San Diego Performance-Based Skills Assessment
VAPS
Virtual Action Planning Supermarket

Introduction

Mild cognitive impairment (MCI) is a controversial clinical entity, initially conceptualized as a transitional zone between normal aging and dementia. The most commonly used criteria for MCI—also known as Mayo criteria—were proposed by Petersen et al. [1,2]. These criteria require (1) a memory complaint, (2) normal activities of daily living, (3) normal general cognitive function, (4) abnormal memory for age and (5) absence of dementia. These criteria have been modified to expand the original MCI concept, including impairments in cognitive domains other than memory. Thus, the clinical phenotypes of amnestic MCI and nonamnestic MCI have been developed, which can both be further classified as single-domain or multiple-domain [3]. Discussion about the MCI criteria and their operationalization is ongoing [4], as the criteria neither specify methods to assess cognitive or functional capacity nor provide cutoff points for cognitive or functional scales to differentiate MCI from mild dementia.
Another important point of discussion is the existence of deficits in activities of daily living (ADL). ADL are divided into basic activities of daily living (BADL) and instrumental activities of daily living (IADL). BADL include self-maintenance skills such as bathing, getting dressed or eating, and IADL consist of more complex activities such as using public transportation, managing finances, or shopping [5]. The assessment of ADL is usually done by using rating scales, which are administered either to the patient or a proxy. Controversy exists about the ability of patients with MCI to adequately rate themselves, as they lack awareness of IADL deficits and overestimate their functional capacity [6-8]. Farias et al., however, reported no lack of awareness in patients with MCI compared with healthy controls [9]. There is evidence that proxies are not always a reliable source of information, as they have a tendency to over- or underestimate IADL deficits [8,10,11]. In some cases, a proxy is not available or has massive knowledge gaps. Direct measures requiring the patient to solve specific IADL-related tasks have better validity and do not have reporter bias. However, they allow observation of only a small excerpt of real-world performance and are quite time-consuming.
It is assumed that IADL require more complex neuropsychological processing capacity than BADL and therefore are more prone to deterioration triggered by cognitive decline [12,13]. Functional deficits have been observed early in the course of decline [14-16]. In an analysis of studies with a focus on BADL and IADL in subjects with MCI, dementia or no cognitive deficits, Nygård [17] suggested that IADL can be impaired before the onset of dementia and should therefore be included in the diagnosis of MCI.
These findings were taken into account by Winblad et al. [18], who proposed the following criteria for MCI: (1) not normal, not demented; (2) cognitive decline; and (3) preserved BADL and/or minimal impairment in complex instrumental functions. Thus, the criterion of “normal activities of daily living” has been revised to a less stringent one allowing for discrete IADL deficits in patients with MCI.
Over the last 15 years, a large amount of research has been conducted on IADL deficits in MCI. The aim of the present review is to summarize research results regarding the performance of patients with MCI in specific IADL (sub)domains compared with persons who are cognitively normal and/or patients with dementia. In addition, sample characteristics and applied IADL assessment methods—performance-based instruments versus self- and/or informant-reported questionnaires or interviews—are investigated.

Methods

Data sources

To identify relevant published papers, the electronic databases PubMed, Web of Science and PsycINFO were searched in December 2013. Publication dates were set from January 1999 to December 2013. This restriction was chosen to identify only papers that were published after the introduction of Petersen’s MCI definition [2]. The search terms “mild cognitive impairment” (MeSH term) or “MCI” were used in combination with the terms “activities of daily living” (MeSH term) or “ADL” or “instrumental activities of daily living” or “IADL” or “everyday functioning” or “functional ability” or “functional capability” or “functional deficits” or “functional impairment.” After removal of duplicates, 497 articles were retrieved from the 3 searched databases.

Selection criteria

Titles and abstracts of the retrieved articles were screened by two authors (KJ and MD) independently and were rated to assess their relevance to the research question. If inconsistencies occurred, a third author (LH) was consulted. The following selection criteria were applied. (1) The abstract indicated that the focus of the study was the investigation of IADL in MCI versus healthy controls and/or dementia patients. (2) General IADL and/or specific subdomains were investigated. (3) The method of IADL assessment was standardized. (4) MCI was defined according to Petersen and/or Winblad criteria [2,3,18]. (5) No other concepts, such as cognitive impairment, no dementia [19,20], aging-associated cognitive decline [21] or age-associated memory impairment [22], were used. (6) The original article was written in English.
Articles that met the outlined criteria were included in the present review. Reference lists of the selected articles were searched to retrieve further relevant articles. Effect sizes (Cohen’s d) were calculated to allow a better evaluation of clinical relevance.

Results

In total, 34 of the 497 papers were selected for review. Owing to the broad focus of the search terms to ensure retrieval of all relevant articles, the majority of articles did not meet the inclusion criteria (that is, no definition of MCI criteria, use of concepts other than Petersen and/or Winblad criteria). A further three articles were selected from among the reference lists of the selected papers. Thus, the content of the present review is formed from a total of 37 articles.

Mild cognitive impairment sample characteristics

For the diagnosis of MCI, the criteria of Petersen or Winblad were applied across studies; their operationalization, however, varied. One-third of the studies used the original Petersen criteria supplemented by cutoffs on specific neuropsychological tests [15,23-34]. In the remaining studies, the use of the original clinical criteria published by Petersen et al. [2] was reported without specific cutoff values or with a combination of Petersen and Winblad criteria. Mean Mini Mental State Examination (MMSE) [35] scores ranged from 23.1 [36] to 28.7 points [37] for MCI samples, from 26.5 [36] to 29.4 points [30,38] for normal control samples and from 16.4 [39] to 25.5 points [40] for Alzheimer’s disease (AD) samples. In each examined study, however, the MMSE score for the MCI group was lower than that for the comparative control group and higher than that for the dementia sample.

Study types and/or designs

The majority of the reported studies followed a cross-sectional design (29 studies [15,23-26,29,30,33,34,36-38,40-56]), and eight studies applied a longitudinal design [27,28,32,57-61]. In five of the longitudinal studies, risk of conversion to AD depending on IADL impairment was also assessed [27,28,32,58,60].

Assessment instruments used

Altogether, 31 different instruments were used to assess IADL in patients with MCI (see Table 1 for details), including performance-based instruments, self- and informant-report rating questionnaires, and structured interviews. Of the 37 studies, 15 relied solely on informant-report rating questionnaires [23,28,29,31,33,40-43,45-48,54,58], 10 relied solely on performance-based assessments [24,26,30,32,38,50-53,57] and 6 relied solely on self-report rating instruments [27,36,55,56,59,61]. Three studies used both informant-report questionnaires and performance-based assessments [25,34,60]. Interestingly (and inconsistently), in three studies [15,25,44], the IADL of patients with MCI were rated by informants, whereas normal control subjects rated their IADL functioning themselves.
Table 1
Instruments used for instrumental activities of daily living assessment a
Abbreviation
Full instrument name
Type
IADL domains
Psychometric properties
Performance-based assessment instruments
 
DAFS [62]
Direct Assessment of Functional Status
P
6 domains: time orientation, communication, financial skills, shopping, grooming, eating
Good interrater and test–retest reliability, good evidence of discriminant and convergent validity, ceiling effects for time orientation, identify change and shopping
DOT [34]
Day-Out Task
P
8 tasks to prepare a day out (including packing a picnic basket, planning a bus route, gathering correct change for bus ride)
Interrater reliability: 96.92% agreement
EPT [63]
Everyday Problems Test
P
Problem solving related to medication use, meal preparation, telephone use, shopping, financial management, household management, transportation
Test–retest reliability: r = 0.93, internal consistency (Cronbach’s α) = 0.88. Validity: significant correlations with direct observation of older adults’ performance of everyday tasks (r = 0.67), older adults’ self-reports (r = 0.23) and dementia patients’ self-reports (r = 0.36)
FCI [64]
Financial Capacity Instrument
P
7 domains: basic monetary skills, financial conceptual knowledge, cash transactions, checkbook management, bank statement management, financial judgment, bill payment
For all subdomains: test–retest reliability r > 0.8, internal consistency (Cronbach’s α) > 0.8
META [53]
Management of Everyday Technology Assessment
P
10 technology-related items (including performing actions in a logical sequence, turning a button)
Acceptable person response validity
TFLS [65]
Texas Functional Living Scale
P
5 domains: time/orientation, money, communication, dressing, memory
Test–retest reliability: r = 0.93 in AD sample, test–retest reliability in control group: r = 0.52, strong correlation with MMSE scores (r = 0.92)
TIADL [66]
Timed Instrumental Activities of Daily Living
P
5 domains: shopping, finances, medication, telephone use, locating information on food labels (speed and accuracy)
Test–retest reliability: r = 0.85
UAB-DA [67]
University of Alabama at Birmingham Driving Assessment
P
Real-world, standardized route: lane control, gap judgment, turning, maintaining proper speed, stopping distance, signaling, obeying traffic signs, preturn and postturn position, spacing, steer steadiness, precrossing and postcrossing position, and proper scanning of driving space
Not reported
UCSD-UPSA [68]
University of California San Diego Performance-Based Skills Assessment
P
5 domains: household chores, communication, finances, transportation, planning recreational activities
Test–retest reliability: r = 0.92
VAPS [52]
Virtual Action Planning Supermarket
P
Virtual reality supermarket, 8 parameters: total distance, total time in seconds, number of items purchased, number of correct actions, number of incorrect actions, number of pauses, combined duration of pauses, time to pay
Validity (correlations between VAPS performance and executive functions): r = −0.40 to r = −0.63
Self-report and informant-report rating instruments
 
ADCS-ADL [69]
Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory
I
23 items (including shopping, hobbies, personal appliances; both IADL and BADL)
Moderate to good retest reliability, floor effects for financial abilities in individuals with dementia
ADCS-MCI-ADL-18 [69]
18-item Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairment
I
18 items (including shopping, hobbies, personal appliances; both IADL and BADL)
Not reported
ADCS-MCI-ADL-24 [45]
24-item Alzheimer’s Disease Cooperative Study/Activities of Daily Living scale adapted for patients with mild cognitive impairment
I
24 items (original ADCS-MCI-ADL scale plus 6 MCI-specific items, including driving a car, organizing medication)
Not reported
ADL-PI [70]
Activities of Daily Living-Prevention Instrument
I
15 items (including completing and/or organizing activities, taking medication, using telephone, finding belongings, managing finances)
Retest reliability: from r = 0.69 to r = 0.74
Bayer-ADL [71]
Bayer Activities of Daily Living Scale
I
25 items (2 BADL items, 18 specific IADL items, 5 items for cognitive functions)
Internal consistency (Cronbach’s α > 0.98)
DAD [72]
Disability Assessment for Dementia
I
IADL part with 23 items (meal preparation, telephoning, going on an outing, finances, medication, housework, leisure) and BADL part with 17 items
Internal consistency (Cronbach’s α = 0.96), interrater reliability (ICC = 0.95), test–retest reliability (ICC = 0.96)
DAD-6 [40]
6-item Disability Assessment for Dementia
I
6 items: meal preparation, telephoning, going on an outing, handling finances and correspondence, medication, leisure, housework
Not reported
DHQ [59]
Driving Habits Questionnaire
S
Driving difficulty in 8 different situations and driving frequency
Retest reliability: from r = 0.65 to r = 0.86 for the 8 situations
ETUQ [56]
Everyday Technology Use Questionnaire
S
86 items (including questions about technology at home and outside, communication)
Acceptable levels of internal scale validity, unidimensionality, and person response validity
FAQ [73]
Functional Activities Questionnaire
S/I
10 items (including finances, shopping, remembering appointments, playing games, preparing a meal, traveling, remembering appointments)
Not reported
FC-ADL [74]
Functional Capacities for Activities of Daily Living
I
50 statements reflecting possible IADL difficulties
Not reported
4-IADL [27]
4 IADL scale items chosen from Lawton and Brody’s Instrumental Activities of Daily Living [5]
S
4 items: telephone use, finances, medication, transportation
Not reported
9-IADL [58]
9-item IADL scale
I
9 items: medication responsibility, ability to buy food, to prepare meals, to keep the home clean, to use the telephone, to handle finances, to use public transportation, to orientate oneself outside, to visit people
Not reported
IQCODE [75]
Informant Questionnaire on Cognitive Decline in the Elderly
I
26 items (including finances, communication, memory, household appliances)
Cronbach’s α = 0.96, correlation with MMSE (r = 0.74)
KI-IADL [34]
Knowledgeable Informant report about Instrumental Activities of Daily Living
I
50 questions assessing 10 IADL domains: using the phone, traveling, shopping, preparing meals, household activities, conversation, organization, social functioning, medication management, financial management
Not reported
L&B IADL [5]
Lawton and Brody’s Instrumental Activities of Daily Living
S/I
8 items: shopping, grooming, medication responsibility, handling finances, mode of transportation, telephone use, food preparation, telephone use
Interrater correlation: r = 0.85
ROIL [76]
Record of Independent Living
I
37 items assessing 3 domains: activities, communication, behavior
Not reported
SR-IADL [77]
Self-report Instrumental Activities of Daily Living
S
Items include handling money, keeping appointments, planning meals (IADL performance and difficulty)
Reliability: r = 0.74
S-IADL [78]
Seoul-Instrumental Activities of Daily Living
S/I
15 items (including ability to prepare a balanced meal, remember appointments, ability to keep financial records, remember to take medication)
Good reliability and validity
SIB-R [79]
Scales of Independent Behavior–Revised
S/I
13 subscales organized into 4 adaptive behavior clusters: (1) social interaction and communication, (2) personal living, (3) community living, (4) motor skills
Self-report: internal consistency (Cronbach’s α) = 0.92, test–retest reliability: r = 0.80
Informant-report: internal consistency (Cronbach’s α) = 0.95, test–retest reliability: r = 0.84
T-ADLQ [54]
Technology–Activities of Daily Living Questionnaire
I
7 subscales (self-care, household care, employment and recreation, shopping and money, travel, communication, technology)
Cronbach’s α = 0.86; validity: significant correlations with the MMSE (r = −0.70)
aAD, Alzheimer’s disease; ADL, Activities of daily living; BADL, Basic activities of daily living; I, Informant-report; IADL, Instrumental activities of daily living; ICC, Intraclass correlation coefficient; MMSE, Mini Mental State Examination; P, Performance-based; S, Self-report.

Mild cognitive impairment subtypes

According to Petersen et al. [1], MCI has two major subtypes: amnestic and nonamnestic. Both can be further divided into single-domain and multidomain types. Among the 37 studies included in this review, IADL performance was analyzed between MCI subtypes in 8 studies [23,31,33,37,40,48,58,61].

Instrumental activities of living in patients with mild cognitive impairment

Among the 37 studies included in this review, all but 2 studies [38,42] found IADL deficits in patients with MCI compared with control subjects without cognitive impairment on at least one applied instrument. In the following sections, we first report results of studies investigating global IADL (see Table 2), then results of studies in which informant-report measures were used and studies using self-report measures (see Table 3).
Table 2
Studies investigating global instrumental activities of daily living functioning a
Author
Year
MCI criteria
Number of subjects
Mean age, yr (SD)
Mean MMSE score (SD)
IADL measures used
Results and effect sizes (Cohen’s d )
Performance-based instruments
Binegar et al. [57]
2009
Petersen
30 MCI
MCI 72.8 (7.9)
MCI 27.3 (2.2)
TFLS
Total score: MCI < NC (d = 0.61); subscales: significant for memory subscale (d = 0.85), but not for time/orientation, money, communication, dressing
Clinical
30 NC
NC 73.7 (6.9)
NC 29.2 (1.0)
ns
significant
Giovannetti et al. [24]
2008
Petersen
25 MCI
MCI 72.2 (6.7)
MCI 27.6 (1.4)
NAT
Total score: NC > MCI > AD; MCI versus NC: d = 1.05, MCI versus AD: d = 1.46
Error score: NC < MCI < AD; MCI versus NC: d = 0.74, MCI versus AD: d = 1.78
1.5 SD below
18 NC
NC 73.1 (3.2)
NC 28.5 (1.0)
 
MMSE ≥25
25 mild AD
AD 73.6 (3.8)
AD 22.4 (2.8)
ns
(NC = MCI) > AD, P < 0.05
Goldberg et al. [25]
2010
Petersen
26 MCI
MCI 77.5 (7.1)
MCI 26.1 (2.3)
UCSD-UPSA
UCSD-UPSA: NC > MCI > AD; MCI versus NC: d = 0.86, MCI versus AD: d = 1.81
ADCS-ADL: (NC = MCI ) > AD; MCI versus AD: d = 1.81
1.5 SD below
50 NC
NC 68.8 (9.9)
NC 28.5 (1.5)
Additional informant-report: ADCS-ADL (NC: self-report)
CDR 0.5
22 AD
AD 78.4 (5.4)
AD 20.3 (3.4)
MMSE ≥24
Pereira [60]
2010
Petersen
31 MCI
MCI 72.6 (7.0)
MCI 27.3 (2.3)
DAFS
DAFS total score NC > MCI > AD; MCI versus NC: d = 1.58, MCI versus AD: d = 2.18
DAFS subdomains: NC > MCI for finances and shopping, but not time orientation, communication, grooming, eating, which were worse only in AD;
IQCODE total score: NC > MCI > AD; MCI versus NC: d = 1.00, MCI versus AD: d = 0.77
Clinical
32 NC
NC 71.6 (5.6)
NC 28.8 (1.5)
26 AD
AD 77.9 (6.0)
AD 19.5 (5.5)
Additional informant-report: IQCODE
AD > (MCI/NC)
AD < (MCI = NC)
Schmitter-Edgecombe et al. [34]
2012
Petersen
38 MCI
MCI 70.5 (8.6)
Not reported
DOT
DOT: MCI < NC for completion time (d = 0.60) and accuracy (d = 0.61)
1.5 SD below
38 NC
NC 69.3 (7.9)
Additional informant-report: KI-ADL
KI-ADL: MCI < NC (d = 0.50)
ns
 
Wadley et al. [50]
2008
Petersen
50 MCI
MCI 70.0 (7.9)
Not reported
Timed IADL
MCI = NC for accuracy
Clinical
59 NC
NC 67.8 (7.1)
MCI < NC for speed (d = 0.75), significant subdomains telephone (d = 0.56), grocery (d = 0.75), medication (d = 0.51), nutrition information (d = 0.52)
ns
Informant-report rating instruments
Ahn et al. [41].
2009
Petersen/Winblad
66 MCI
MCI 70.8 (7.3)
MCI 24.8 (3.1)
Seoul-IADL
MCI < NC (d = 1.62)
1.5 SD below
61 NC
NC 64.4 (5.6)
NC 27.6 (1.4)
CDR 0.5
significant
Boeve et al. [42]
2003
Petersen
13 MCI
MCI 94.3 (2.6)
MCI 26.8 (1.6)
ROIL
MCI = NC, MCI > dementia (d = 2.93)
Clinical
56 NC
NC 93.8 (2.5)
NC 27.9 (2.3)
42 Dementia
Dementia 94.8 (2.6)
Dementia 18.6 (5.0)
ns
AD < (MCI = NC)
Brown et al. [15]
2011
Petersen
394 MCI
MCI 74.9 (7.4)
MCI 27.0 (1.8)
FAQ (NC: self-report)
Severity of deficits: NC > MCI > AD; MCI versus NC: d = 1.04, MCI versus AD: d = 1.71
Number of deficits: NC < MCI < AD; MCI versus NC: d = 1.28, MCI versus AD: d = 1.62
1.5 SD below
229 NC
NC 75.9 (5.0)
NC 29.1 (1.0)
CDR 0.5
193 AD
AD 75.3 (7.5)
AD 23.3 (2.1)
MMSE ≥24
ns
significant
Jefferson et al. [43]
2008
Petersen/Winblad
38 MCI
MCI 74.6 (7.5)
MCI 28.0 (1.7)
L&B IADL
L&B IADL: MCI = NC, FC-ADL: MCI < NC (d = 0.84)
Clinical
39 NC
NCI 72.4 (5.5)
NC 29.3 (0.9)
FC-ADL
ns
significant
Mariani et al. [44]
2008
Petersen/Winblad
132 MCI
MCI 76.1 (5.8)
MCI 25.7 (1.6)
L&B IADL
(MCI: informant-report, NC: self-report)
MCI < NC (d = 0.29)
below normality cutoff
249 NC
NC 72.2 (7.5)
NC 28.1 (1.2)
significant
significant
Pedrosa et al. [45]
2010
Petersen/Winblad
30 MCI
MCI 75.7 (6.4)
MCI 24.4 (3.3)
ADCS-MCI-ADL-18 ADCS-MCI-ADL-24 L&B-IADL
ADCS-MCI-ADL-18: NC > MCI > AD; MCI versus NC: d = 1.39, MCI versus AD: d = 2.27
ADCS-MCI-ADL-24: NC > MCI > AD; MCI versus NC: d = 1.67, MCI versus AD: d = 2.33
L&B IADL: NC > MCI > AD; MCI versus NC: d = 2.0, MCI versus AD: d = 2.89
1 SD below
31 NC
NC 72.2 (8.0)
NC 27.7 (3.0)
33 AD
AD 76.1 (7.5)
AD 16.5 (5.2)
Perneczky et al. [47]
2006
Petersen/Winblad
48 MCI
MCI 69.2 (8.3)
MCI 26.5 (2.3)
ADCS-MCI-ADL-18 Bayer-ADL IQCODE
ADCS-MCI-ADL-18: MCI < NC (d = 1.98)
Bayer-ADL: MCI < NC (d = 1.95)
IQCODE: MCI < NC (d = 1.09)
1 SD below
42 NC
NC 66.7 (9.3)
NC 29.3 (0.7)
CDR 0.5
ns
significant
Perneczky et al. [46]
2006
Petersen/Winblad
45 MCI
MCI 69.2 (8.3)
MCI 26.9 (1.4)
ADCS-MCI-ADL-18 Bayer-ADL
ADCS-MCI-ADL-18: MCI < NC (d = 1.89)
Bayer-ADL: MCI < NC (d = 2.44)
1 SD below
30 NC
NC 66.7 (9.3)
NC 29.3 (0.7)
CDR 0.5
ns
Reppermund et al. [29]
2011
Petersen
293 MCI
MCI 78.8 (4.7)
MCI 28.0 (1.5)
Bayer-ADL
Bayer-ADL total: MCI < NC (d = 0.32)
1.5 SD below
469 NC
NC 78.3 (4.7)
NC 28.8 (1.2)
Bayer-ADL high cognitive demand: MCI < NC (d = 0.40)
ns
Bayer-ADL low cognitive demand: MCI = NC
Reppermund et al. [28]
2013
Petersen
227 MCI
MCI 78.6 (4.4)
MCI 28.3 (1.4)
Bayer-ADL
Bayer-ADL total: MCI < NC (d = 0.39)
1.5 SD below
375 NC
NC 77.9 (4.6)
NC 28.9 (1.2)
 
Bayer-ADL high cognitive demand: MCI < NC (d = 0.40)
Bayer-ADL low cognitive demand: MCI < NC (d = 0.27), IADL performance at baseline predicted conversion to dementia at 2-year follow-up
ns
significant
Self-report rating instruments
Kim et al. [36]
2009
Winblad
255 MCI
MCI 72.0 (6.0)
MCI 23.1 (4.5)
Seoul-IADL
MCI < NC (d = 0.27)
1 SD below
311 NC
NC 70.7 (6.0)
NC 26.5 (3.3)
significant
significant
Peres et al. [27]
2006
Petersen
285 MCI
Total sample: 80.8 (5.6)
Not reported
4-IADL
NC > MCI > dementia
1.5 SD below
828 NC
149 dementia
Comparison of MCI subtypes: informant-report rating instruments
Aretouli et al. [23]
2010
Petersen
124 MCI
MCI 76.3 (7.5)
MCI 28.2 (1.3)
ADL-PI IQCODE
ADL-PI: MCI < NC, P < 0.001; all MCI subgroups < NC, P < 0.001, md = sd; am = nonam
IQCODE: MCI < NC, P < 0.001; true for all subgroups; multiple > single, am = nonam
1.5 SD below
(36 asMCI
NC 72.4 (7.3)
NC 29.3 (0.9)
CDR 0.5
45 amMCI
significant
significant
26 nasMCI
17 namMCI)
68 NC
Luck et al. [58]
2011
Winblad
161 MCI
MCI 81.9 (5.0)
Not reported
9 IADL items (Schneekloth and Potthoff [80])
MCI < NC (aMCI = naMCI; aMCI < NC (d = 0.17), naMCI = NC)
MCI + IADL deficits: higher risk of conversion to dementia
MCI + IADL: 47.4% versus MCI-IADL: 31.4%;
NC + IADL: 26.7% versus NC-IADL: 8.0%
1 SD below
(36 asMCI
(aMCI 81.6 (4.8),
42 amMCI
naMCI 82.2 (5.2))
60 nasMCI
NC 81.2 (4.7)
23 namMCI)
ns
723 NC
 
de Rotrou [40]
2012
Petersen
53 MCI
MCI 78.6 (7.3)
MCI 26.2 (2.2)
DAD-6
NC > MCI > AD; MCI versus NC: d = 1.29, MCI versus AD: d = 1.66
NC > sdMCI (d = 1.59), sdMCI > mdMCI (d = 1.37)
Clinical
(29 sdMCI
NC 80.9 (4.2)
NC 29.1 (1.0)
 
24mdMCI)
Dementia 80.6 (6.2)
Dementia 25.5 (1.8)
55 NC
ns
All significant
31 Dementia
Tam et al. [48]
2007
Petersen/Winblad
54 asMCI
asMCI 79.3 (6.1)
asMCI 25.4 (3.0)
DAD
IADL subscale: (NC = asMCI) > amMCI > AD; amMCI versus NC: d = 0.98, asMCI versus amMCI: d = 0.80, asMCI versus AD: d = 2.93, amMCI versus AD: d = 1.71
CDR 0.5
93 amMCI
amMCI 80.1 (6.5)
amMCI 22.3 (3.1)
1 SD below
78 NC
NC 77.1 (5.1)
NC 27.2 (2.1)
85 AD
AD 84.5 (5.9)
AD 17.9 (3.2)
Teng et al. [31]
2010
Petersen
1108 MCI
as 77.0 (9.2)
as 27.8 (1.8)
FAQ
NC > asMCI/amMCI/nasMCI; asMCI = amMCI, nasMCI = namMCI
MMSE ≥24
(532 asMCI
am 75.3 (8.5)
am 27.4 (1.8)
340 amMCI
nas 74.1 (8.6)
nas 28.2 (1.7)
162 nasMCI
nam 73.0 (6.8)
nam 27.8 (1.5)
74 namMCI)
NC 74.8 (9.1)
NC 29.0 (1.2)
   
3,036 NC
significant
   
Yeh et al. [33]
2011
Petersen
56 asMCI
asMCI 77.5 (6.7)
asMCI 26.6 (1.6)
DAD
NC > MCI (as = am) > AD; asMCI versus NC: d = 0.9, amMCI versus NC: d = 1.06, asMCI versus AD: d = 2.23, amMCI versus AD: d = 1.9
1 SD below
94 amMCI
amMCI 78.9 (5.8)
amMCI 25.8 (1.6)
MMSE ≥24
64 NC
NC 76.5 (6.6)
NC 28.5 (1.3)
102 AD
AD 79.6 (6.1)
AD 20.9 (3.1)
Comparison of MCI subtypes: self-report rating instruments
Wadley et al. [61]
2007
Petersen/Winblad
84 aMCI
aMCI 77.0 (7.0)
aMCI 26.0 (1.9)
IADL (Home Care questionnaire)
IADL performance: aMCI/mdMCI < NC, naMCI = NC; aMCI versus NC: d = 0.23, mdMCI versus NC: d = 0.31; aMCI < naMCI: d = 0.23
IADL difficulty: all MCI subgroups < NC; aMCI versus NC: d = 0.57, naMCI versus NC: d = 0.27, mdMCI versus NC: d = 0.57; aMCI < naMCI: d = 0.23
1.5 SD below
171 naMCI
naMCI 76.5 (6.2)
naMCI 26.2 (2.1)
89 mdMCI
mdMCI 78.8 (6.6)
mdMCI 25.1 (1.8)
2,110 NC
NC 72.9 (5.4)
NC 27.6 (1.8)
significant
Comparison of MCI subtypes and all three types of instruments
Burton et al. [37]
2009
Petersen/Winblad
6 asMCI
asMCI 79.5 (5.7)
asMCI 26.8 (2.5)
Performance-based: EPT
Self-report: SIB-R: NC > mdMCI (d = 0.71), sdMCI > mdMCI (d = 0.45), L&B: MCI = NC; L&B IADL: MCI = NC
Informant-report SIB-R: NC > sdMCI (d = 0.46), NC > mdMCI (d = 0.51); L&B IADL: MCI = NC
EPT: NC > sdMCI > mdMCI; sdMCI versus NC: d = 0.50, sdMCI versus mdMCI: d = 1.54
1 SD below
39 nasMCI
nasMCI 77.5 (5.6)
nasMCI 28.7 (1.3)
Self-report: L&B IADL, SIB-R;
Informant-report: L&B IADL, SIB-R
19 amMCI
amMCI 82.0 (5.0)
amMCI 28.2 (1.3)
28 namMCI
namMCI 79.6 (4.9)
namMCI 28.7 (1.1)
158 NC
NC 73.6 (4.7)
NC 28.9 (1.2)
aAD, Alzheimer’s disease; ADCS-ADL, Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory; ADCS-MCI-ADL-18, 18-item Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairment; ADCS-MCI-ADL-24, 24-item Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory adapted for patients with mild cognitive impairment; ADL, Activities of daily living; ADL-PI, Activities of Daily Living-Prevention Instrument; am, Amnestic multiple domain; aMCI, Amnestic mild cognitive impairment; as, Amnestic single domain; BADL, Basic activities of daily living; Bayer-ADL, Bayer Activities of Daily Living Scale; CDR, Clinical dementia rating; DAD, Disability Assessment for Dementia; DAD-6, 6-item Disability Assessment for Dementia; DAFS, Direct Assessment of Functional Status; DHQ, Driving Habits Questionnaire; DOT, Day-Out Task; EPT, Everyday Problems Test; ETUQ, Everyday Technology Use Questionnaire; FAQ, Functional Activities Questionnaire; FC-ADL, Functional Capacities for Activities of Daily Living; FCI, Financial Capacity Instrument; FC-IADL, Functional Capacities for Instrumental Activities of Daily Living; IADL, Instrumental activities of daily living; 4-IADL, 4-item Instrumental Activities of Daily Living scale items chosen from Lawton and Brody; 9-IADL, 9-item Instrumental Activities of Daily Living scale; ICC, Intraclass correlation coefficient; IQCODE, Informant Questionnaire on Cognitive Decline in the Elderly; KI-IADL, Knowledgeable Informant report about Instrumental Activities of Daily Living; L&B IADL, Lawton and Brody’s Instrumental Activities of Daily Living; MCI, Mild cognitive impairment; md, Multiple domain; META, Management of Everyday Technology Assessment; MMSE, Mini Mental State Examination; nam, Nonamnestic multiple domain; naMCI, Nonamnestic mild cognitive impairment; nas, Nonamnestic single domain; NAT, Naturalistic action task; NC, Normal control; NIA-AA, National Institute on Aging and Alzheimer’s Association; ns, nonsignificant; ROIL, Record of Independent Living; sd, Single domain; SD, Standard deviation; S-IADL, Seoul-Instrumental Activities of Daily Living; SIB-R, Scales of Independent Behavior–Revised; SR-IADL, Self-report Instrumental Activities of Daily Living; TADL-Q, Technology–Activities of Daily Living Questionnaire; TFLS, Texas Functional Living Scale; TIADL, Timed Instrumental Activities of Daily Living; UAB-DA, University of Alabama at Birmingham Driving Assessment; UCSD-UPSA, University of California, San Diego Performance-Based Skills Assessment; VAPS, Virtual Action Planning Supermarket.
Table 3
Studies investigating specific instrumental activities of daily living domains a
Author
Year
MCI criteria
Number of subjects
Mean age, yr (SD)
Mean MMSE score (SD)
IADL measures
Results and effect sizes (Cohen’s d )
Financial capacity: performance-based instruments
Griffith et al. [26]
2003
Petersen
21 MCI
MCI 68.1 (8.8)
MCI 28.4 (1.2)
FCI
NC > MCI > AD; MCI versus NC: d = 1.14, MCI versus AD d = 1.21
CDR 0.5
21 NC
NC 66.7 (7.2)
NC 29.3 (1.0)
22 AD
AD 71.5 (9.2), ns
AD 24.1 (2.6)
Sherod et al. [30]
2009
Petersen
113 MCI
MCI 70.3 (7.4)
MCI 28.1 (1.9)
FCI
NC > MCI > AD; MCI versus NC: d = 1.03, MCI versus AD: d = 0.87
1.5 SD below
85 NC
NC 67.2 (8.2)
NC 29.4 (0.9)
43 AD
AD 73.8 (8.5)
AD 24.6 (2.9)
all significant
Triebel et al. [32]
2009
Petersen
87 MCI
ADcon 74.4 (6.0)
ADcon 27.0 (1.9)
FCI
NC > MCI; ADnon versus NC: d = 0.83, ADcon versus NC: d = 1.83
1.5 SD below
(25 ADcon, 62 ADnon)
ADnon 68.5 (7.5)
ADnon 28.6 (1.4)
76 NC
NC 66.7 (8.5)
NC 29.4 (1.0)
Management of everyday technology: performance-based instruments
Malinowsky et al. [53]
2010
Petersen
33 MCI
MCI 70.5 (8.4)
MCI 27.5 (1.9)
META
NC > MCI > AD, MCI versus NC: d = 0.66, MCI versus AD: d = 1.23
45 NC
NC 73.2 (9.7)
NC 29.3 (1.1)
38 AD
AD 75.3 (9.1)
AD 23.5 (3.3)
Malinowsky et al. [38]
2012
Petersen/Winblad
33 MCI
MCI 70.8 (8.6)
MCI 27.5 (1.9)
META
NC > AD, MCI = NC
42 NC
NC 72.6 (9.7)
NC 29.4 (1.0)
35 AD
AD 75.5 (9.2)
AD 23.5 (3.4)
ns
Management of everyday technology: informant-report rating instruments
Munoz-Neira et al. [54]
2012
Winblad
21 MCI
MCI 71.3 (9.1)
MCI 26.1 (2.5)
T-ADLQ
Total score: NC > MCI > AD, MCI versus NC: d = 0.62, MCI versus AD: d = 1.47
Subscales: NC > MCI on 2 subscales: employment and recreation: d = 0.54, travel: d = 0.55
44 NC
NC 74.1 (7.3)
NC 27.8 (2.3)
63 AD
AD 73.9 (8.7)
AD 17.9 (5.8)
Management of everyday technology: self-report rating instruments
Nygård et al. [55]
2011
Petersen/Winblad
37 MCI
MCI 67.0 (7.47)
MCI 27.5 (2.1)
ETUQ (support of proxy possible for patients with AD and MCI)
Perceived relevance of ET: NC > MCI > AD; MCI versus NC: d = 0.51, MCI versus AD: d = 1.26
44 NC
NC 69.0 (9.58)
NC 29.1 (1.1)
37 AD
AD 72.0 (8.92)
AD 25.4 (2.8)
ns
ns
Perceived difficulty of ET: NC < MCI < AD; MCI versus NC: d = 0.82, MCI versus AD: d = 1.26
Rosenberg et al. [56]
2009
Petersen
30 MCI
MCI 74.0 (6.9)
MCI 27.0 (2.4)
ETUQ (support of proxy possible for patients with AD and MCI)
Perceived relevance of ET: NC > MCI = AD; MCI versus NC: d = 1.66
93 NC
NC 74.0 (7.6)
NC 28.0 (1.7)
Perceived difficulty of ET: NC < MCI < AD; MCI versus NC: d = 0.59, MCI versus AD: d = 1.00
34 AD
AD 73.0 (8.4)
AD 24.0 (3.3)
ns
Driving capacity: performance-based instruments
Wadley et al. [51]
2009
Petersen
46 MCI
MCI 71.3 (7.8)
Not reported
UAB-DA
MCI < NC, d = 0.46
59 NC
NC 67.1 (6.7)
significant
Driving capacity: self-report rating instruments
O’Connor et al. [59]
2010
Petersen/Winblad
304 MCI
MCI 76.8 (6.5)
Not reported
DHQ
(aMCI = naMCI = mdMCI) < NC (driving frequency, driving difficulty, driving space) differed at baseline and faster rates of decline
Driving frequency: aMCI versus NC: d = 0.31, naMCI versus NC: d = 0.24, mdMCI versus NC: d = 0.14
Driving difficulty: aMCI versus NC: d = 0.35, naMCI versus NC: d = 0.36, mdMCI versus NC: d = 0.45
Driving space: aMCI versus NC: d = 0.42, naMCI versus NC: d = 0.51, mdMCI versus NC: d = 0.43
1.5 SD below
(82 aMCI
NC 72.6 (5.3)
140 naMCI
significant
82 mdMCI)
2,051 NC
Shopping capacity: performance-based instruments
Werner et al. [52]
2009
Petersen
30 MCI
MCI 69.3 (7.4)
MCI 27.5 (1.3)
VAPS
MCI < NC; significant subscales: distance d = 0.29, trajectory duration: d = 1.16, duration of pauses: d = 0.89
30 NC
NC 69.6 (7.3)
NC 29.4 (0.7)
ns
significant
aAD, Alzheimer’s disease; ADcon, Converters to Alzheimer’s disease; ADnon, Nonconverters to Alzheimer’s disease; aMCI, Amnestic mild cognitive impairment, both single and multiple domains; CDR, Clinical dementia rating; DHQ, Driving Habits Questionnaire; ETUQ, Everyday Technology Use Questionnaire; FCI, Financial Capacity Instrument; MCI, Mild cognitive impairment; mdMCI, Multiple-domain mild cognitive impairment; NC, Normal control; ns, Nonsignificant; UAB-DA, University of Alabama at Birmingham Driving Assessment; VAPS, Virtual Action Planning Supermarket.

Global instrumental activities of daily living rating instruments

Performance-based instruments

Schmitter-Edgecombe et al. [34] designed the Day-Out Task (DOT), which requires multitasking in a real-world setting. Participants have to prepare for a day out and complete related tasks such as planning a bus route or packing specific items in a picnic basket. Patients with MCI required more time to complete the DOT than healthy controls and made more errors while solving the subtasks. By means of the Timed IADL, Wadley et al. [50] investigated both the speed and accuracy of patients with MCI in solving tasks related to shopping, finances, medication, telephone use and locating information on food labels. Patients with MCI took significantly longer than normal controls to solve the tasks and were less accurate. Using the Direct Assessment of Functional Status (DAFS), Pereira et al. [60] found that patients with MCI performed significantly worse than healthy controls and better than AD patients. Financial and shopping skills were the items that differentiated patients with MCI from healthy controls. Binegar et al. [57] applied the Texas Functional Living Scale and detected a significant but small difference between patients with MCI and controls. Interestingly, they mentioned that the performance of patients with MCI on this direct measure was much better (47 points) than that of patients with mild AD (31 points) in a previously conducted study [65].
Using the Naturalistic Action Task, Giovanetti et al. [24] found that patients with MCI performed significantly worse than healthy controls, but better than persons with mild AD, on all three assessed tasks: preparing toast and coffee, wrapping a gift and preparing a lunch box. When cutoff scores were applied, no controls, but 24% of the patients with MCI and 76% of the AD group, fell within the impaired range. Goldberg et al. found a similar pattern of results when they applied a novel performance-based assessment (the University of California San Diego Performance-Based Skills Assessment): The cognitively normal control group outperformed the MCI group, which in turn performed better than the mild to moderate AD group [25]. Interestingly, using the informant-report Alzheimer’s Disease Cooperative Study/Activities of Daily Living Inventory (ADCS-ADL), they detected no significant differences between patients with MCI and persons who were cognitively normal.
All of the performance-based instruments detected significant differences in IADL functioning between patients with MCI and healthy controls, as well as between patients with MCI and patients with dementia, respectively. Furthermore, patients with MCI needed more time to complete tasks than healthy controls and less time than patients with dementia. Calculated effect sizes were medium to large. In terms of effect sizes, the DAFS was the best measure for detecting differences in global IADL functioning between MCI and healthy controls (Cohen’s d = 1.58) and between MCI and AD (Cohen’s d = 2.18).

Informant-report rating instruments

Using the Seoul-IADL, Ahn et al. [41] found deficits in patients with MCI compared with healthy controls in the domains of telephone use, meal preparation, medication intake, management of belongings, keeping appointments, talking about recent events and performing leisure activities and/or hobbies. They concluded that IADL requiring memory or frontal cortex executive functioning are at particular risk of decline in MCI. Jefferson et al. [43] applied an error-based questionnaire of functional capacity (FC-IADL). The FC-IADL measures specific behaviors such as “getting lost in familiar places” and “does not use tools for the proposed use.” On this questionnaire, patients with MCI scored more than 1.5 standard deviations (SD) worse than normal controls. In contrast, no statistically or clinically significant differences were found for the informant-report Lawton and Brody IADL scale.
In contrast, two other studies applying Lawton and Brody’s IADL scale [44,45] showed that patients with MCI had deficits compared with controls regarding shopping, taking medications and handling finances.
Using the Record of Independent Living, Boeve et al. [42] found no significant differences between patients with MCI and healthy controls, but they did observe differences between patients with MCI and controls compared with dementia patients. This study is exceptional within this review because the participants were 90 to 100 years of age. Furthermore, the MCI group was very small (n = 13, compared with 56 healthy controls and 42 patients with dementia). Perneczky et al. [47] applied a questionnaire specifically designed for measuring IADL in MCI—the ADCS-MCI-ADL [69]—and found greater informant-reported impairments for the MCI group than among the age- and sex-matched cognitively normal controls. Pedrosa et al. [45] also reported better ADCS-MCI-ADL scores for healthy controls than for patients with MCI. Consistent observations—that is, differences between patients with MCI and healthy controls—in both studies were observed for finding personal belongings, balancing a checkbook, keeping appointments, using a telephone and talking about recent events. Furthermore, Pedrosa et al. compared the original ADCS-MCI-ADL scale with an extended version. (The authors added six items that they considered useful for MCI populations.) The 24-item version distinguished patients with MCI and healthy controls more reliably than the 18-item version [45]. Reppermund et al. [29], using the Bayer-ADL scale, found significant differences between patients with MCI and healthy controls. This effect was due to deficits of patients with MCI in the domains of observing important dates or events, reading, describing recent events, taking part in a conversation, taking a message, doing two tasks at a time, coping with unfamiliar situations and performing a task while under pressure. Conducting a factor analysis, the authors further subdivided the items into IADL with high or low cognitive demands. Group differences emerged only for the high cognitive demand factor, which consisted mainly of the items mentioned above, which in turn were responsible for the group differences between healthy controls and MCI subjects. The low cognitive demand factor consisted of items such as shopping, using transportation and preparing food. The same work group [28] gathered longitudinal data and again found differences in the Bayer-ADL scale between patients with MCI and healthy controls at baseline and at 2-year follow-up. For healthy controls, Bayer-ADL items with high cognitive demand predicted conversion to MCI and dementia at follow-up. Using the Functional Activities Questionnaire (FAQ), Brown et al. [15] detected significant differences between patients with MCI and healthy controls, and patients with MCI showed more deficits than healthy controls regarding financial skills and remembering events.
With the exception of one study [42], differences between patients with MCI and healthy controls were consistently detected. Deficits regarding financial abilities and memory-related IADL such as keeping appointments or remembering events were common themes across studies. With large effect sizes and consistent results across studies, the informant-reported ADCS-MCI-ADL seems to be a useful tool for global IADL assessment. The Lawton and Brody IADL scale delivered mixed results. Jefferson et al. detected no significant differences between MCI and healthy controls [43], whereas Pedrosa et al. found large effects [45] and Mariani et al. discovered small effects [44]. The same holds true for the Bayer-ADL. Large effects were seen in the two studies by Perneczky et al. [46,47], but only small effects were reported in the studies by Reppermund et al. [28,29].

Self-report rating instruments

Using the Seoul-IADL in a self-rating version, Kim et al. [36] found patients with MCI to be significantly impaired in using a telephone, keeping appointments, talking about recent events and using household appliances, thus replicating the findings of Ahn et al. with the Seoul-IADL in an informant-rating version [41]. In addition, Kim et al. also reported worse performance of the MCI group for transportation and finances. Peres et al. [27] investigated restriction to four IADL items from the Lawton and Brody IADL scale in a self-rating version: telephone use, mode of transport, medication responsibility and handling finances. Patients with MCI were more often restricted in IADL (34.3%) than controls (5.4%) and were less restricted than patients with dementia (91.1%). Interestingly, within a 2-year period, IADL-restricted patients with MCI converted to dementia more frequently than IADL-nonrestricted patients with MCI (30.7% versus 7.8%).

Global instrumental activities of daily living and mild cognitive impairment subtypes

When we analyzed MCI subtypes, differences between MCI subtypes and normal controls were reported for all applied measures except of the Lawton and Brody IADL scale. Looking at effect sizes, the IADL deficits tended to be more pronounced in multiple-domains MCI than in single-domain MCI and also in amnestic MCI than in nonamnestic MCI.

Informant-report rating instruments

Focusing on MCI subtypes, Tam et al. [48] found that the multiple-domains MCI subgroup had an intermediate IADL performance level between those of normal controls and patients with mild dementia on the Disability Assessment for Dementia (DAD) scale. Using the DAD, IADL performance, as well as subjects’ performance regarding initiation or planning and organizing of the IADL subtasks, can be evaluated. The amnestic MCI group had significantly better IADL scores than the multiple-domains MCI group, and their scores were similar to those of the cognitively normal controls. The IADL subscales most frequently impaired in the multiple-domains MCI group were those connected to planning and organizing IADL tasks; initiation of tasks was unaffected.
Aretouli et al. [23] found significant differences between healthy controls and patients with MCI for 12 of 15 items on the Activities of Daily Living-Prevention Instrument. Major difficulties were reported for keeping appointments, using the telephone, remembering current events and finding things at home, and minor difficulties were reported for driving and using transportation, managing finances, organizing and completing activities, and taking medication. An analysis of the MCI subtypes revealed that all four subgroups showed deficits compared with normal controls. However, patients with multiple-domains MCI were not significantly different from those with single-domain MCI, and the amnestic groups did not differ significantly from the nonamnestic groups.
Using the DAD, Yeh et al. [33] reported more IADL deficits for both single-domain amnestic MCI und multiple-domains amnestic MCI than for healthy controls. Both MCI groups had better DAD scores than the mild AD group. When they looked at the DAD scores in detail, though, multiple-domains amnestic patients with MCI had deficits on a larger number of items than single-domain amnestic patients with MCI. Applying the DAD-6 (a shortened version of the DAD), de Rotrou et al. [40] reported similar findings. Using the FAQ, Teng et al. [31] reported better results for normal controls than for patients with MCI. In analyzing the subgroups, they found better results for normal controls than for the amnestic MCI group on all investigated IADL items and better scores than the nonamnestic group on managing bills, preparing taxes, keeping up with current events, attending to media, remembering dates and traveling outside the neighborhood. Luck et al. [58] investigated performance on nine IADL items and detected worse performance of patients with MCI compared with healthy controls. Analyses of MCI subtypes revealed that this effect was stronger for amnestic MCI subtypes.

Self-report rating instruments

Investigating MCI subtypes and normal controls, Wadley et al. [61] found all MCI subgroups reported significantly greater IADL difficulty and worse everyday functioning scores than normal controls at baseline. Over a 3-year period, all MCI groups also showed a significantly steeper decline on the everyday-functioning composite score and IADL performance compared with the cognitively normal group.

One study comparing all three assessment modalities

In a study by Burton et al. [37], three different IADL measures were used that revealed differences between MCI subtypes and healthy controls on the Scales of Independent Behavior–Revised (on both the self- and informant-report version) and the performance-based Everyday Problems Test. No differences between groups emerged with the use of Lawton and Brody’s IADL scale with either the self-report or the informant-report version.

Specific instrumental activities of daily living domains

Financial capacity performance-based instruments

Financial capacity is the best-studied IADL subdomain. The Financial Capacity Instrument (FCI) has been used in three studies [26,30,32]. The FCI assesses financial capacity in seven domains, including monetary skills, financial concepts and bank statement management. All three studies revealed that the overall financial capacity (total score) of patients with MCI was worse than that of healthy controls. The activity “bank statement management” was consistently affected across studies. Griffith et al. [26] additionally found group differences regarding bill payment and financial concepts. Moreover, Triebel et al. [32] reported longitudinal data showing that, at baseline, MCI participants were significantly worse than normal controls on all financial domains and on total scores. Furthermore, the MCI group had been divided into converters and nonconverters to dementia. At baseline, the MCI nonconverter group performed better than the converter group in the domains of financial conceptual knowledge, cash transactions, bank statement management, bill payment and both total scores. No differences were observed for the domains of basic monetary skills, checkbook management, financial judgment and investment decision-making. Over a 1-year period, declines in the domain checkbook management and the total score were observed for the converters, but not for the nonconverters or controls [32].

Management of everyday technology

Performance-based instruments
In 2010, Malinowsky et al. [53] used a standardized observation-based tool (Management of Everyday Technology Assessment) to evaluate ability to manage everyday technology (ET; for example, electronic household appliances, remote controls, cell phones) in patients with mild AD or MCI and controls. They found significant differences between all three groups. Patients with MCI performed worse in using technology than healthy controls did, but better than patients with dementia. In a more recent analysis of the same sample by the same work group [38], significant differences were observed only between healthy controls and patients with dementia when intrapersonal and environmental features were controlled for. They reasoned that what influences a person’s ability to use ET—besides cognitive level or diagnosis—is within-person variability in intrapersonal characteristics and environmental influence (that is, the design of the ET and the context in which it is used).
Informant-rating instruments
Muñoz-Neira et al. [54] added a technology subscale to a Spanish ADL questionnaire. They found significant group differences between healthy controls, patients with MCI and patients with dementia for the total score. Patients with AD had worse scores than patients with MCI and healthy controls on all seven subscales. Comparing patients with MCI and healthy controls, only the recreation and travel subscales differed significantly; no difference was observed for the technology subscale.
Self-report rating instruments
Applying the Everyday Technology Use Questionnaire, Rosenberg et al. [56] investigated the perceived difficulty in use of everyday technologies in samples with AD, MCI and controls. They found significant differences between groups, as well as in the amount of technologies that were considered relevant in each group. Using the same instrument, Nygård et al. [55] could replicate the above-mentioned findings. Furthermore, they found a moderately strong association between engagement in everyday life activities and perceived difficulty in ET use in these three samples.

Driving capacity

Performance-based instruments
Wadley et al. [51] investigated driving ability, which revealed that patients with MCI were significantly more likely than participants who were cognitively normal to be given “less than optimal” ratings for left-hand turns, lane control and the global driving rating. Furthermore, they tended to receive more “less than optimal” ratings on gap judgment and maintaining proper speed. No differences were found for right-hand turns or steering steadiness. The authors noted, however, that the magnitude of difference between MCI participants’ driving performance and that of controls was small, and that, as a group, MCI drivers were not sufficiently impaired to have their driving ability rated as unsafe or unsatisfactory.
Self-report rating instruments
O’Connor et al. [59] investigated 5-year trajectories of mobility indicators, including driving frequency and perceived driving difficulty. The study revealed that driving frequency had a steeper decline in the MCI group compared with healthy controls. Furthermore, driving in both normal and demanding situations was perceived as more difficult by patients with MCI than controls.

Shopping capacity performance-based instruments

Werner et al. [52] directly assessed the IADL domain of shopping by means of a virtual reality supermarket scenario (the Virtual Action Planning Supermarket). They found that patients with MCI covered a significantly higher mean distance, had longer pauses and accordingly took longer to complete their shopping than normal controls. However, the number of purchases, correct or wrong actions, stops and mean time to pay did not differ between groups.

Discussion

This review impressively illustrates that deficits in IADL are consistently present in MCI. Of the 37 included studies, 35 revealed deficits in global IADL or in specific IADL subdomains such as finances, shopping, keeping appointments, driving or ET use. Furthermore, compared with healthy controls, patients with MCI needed longer to complete tasks and tended to be less accurate. Effect sizes were predominantly moderate to large. In analyzing the MCI subtypes, we observed that the IADL deficits tended to be more pronounced in multiple-domains MCI than in single-domain MCI and in amnestic MCI than in nonamnestic MCI, respectively.
In general, patients with MCI had intermediate functional performance between healthy controls and patients with mild AD, particularly in more complex tasks with high cognitive demand. Financial capacity, particularly, was affected in a vast majority of studies. On the general IADL questionnaires, telephone use, responsibility for medication and keeping appointments were the domains most often affected. Nevertheless, there were studies that revealed no deficits in these domains [37,42]. Even when comparing studies in which researchers used the same instrument, such as the Seoul-IADL [36,41], only three matching domains emerged: telephone use, keeping appointments and using household appliances. Similar inconsistencies were observed for Lawton and Brody’s IADL Scale [5]. In two studies in which this instrument was used, investigators did not find any differences between patients with MCI and persons who were cognitively normal [37,43], supporting the argument that this scale is not sensitive enough to detect subtle deficits in MCI. However, researchers in two other studies [44,45] used the same scale and identified impairments in patients with MCI regarding the domains of shopping, medication and finances. One possible explanation for these inconsistencies is the very heterogeneous operationalization of the MCI criteria. Some studies relied solely on a clinical decision, and others used cutoff scores to determine the magnitude of cognitive impairment, but even the cutoff scores varied between 1 SD and 1.5 SD below age- and education-adjusted norms. Furthermore, the mean MMSE scores of MCI subjects ranged from 23.1 [36] to 28.7 points [37], and mean MMSE scores of normal controls ranged from 26.5 [36] to 29.4 points [30]. The problem with studies including patients with MCI with very low MMSE scores is that IADL deficits may be due to already present, but not yet diagnosed, dementia. In a long-term study of patients with mild AD (MMSE score range, 20 to 26), 45% to 65% could not perform usual IADL tasks at baseline, and 70% to 85% of the remaining patients needed assistance with IADL after 3 years [81]. For future research, it would be helpful to conduct (sub)analyses with patients with MCI who have a MMSE score of 27 points or higher to ensure that they have not already converted to dementia. Another possibility is to use cutoff scores of 1 SD, instead of 1.5 SD, below age- and education-adjusted norms in neuropsychological tests [82]. Moreover, it should be taken into consideration that the MMSE is a rather insensitive measure for cognitive functioning, as it is not adjusted for age and education. In general, the use of MMSE cutoff scores to define MCI should be scrutinized.
In reviewing the selected articles, we found that the variety of assessment instruments applied to assess IADL in MCI was impressive; 31 different instruments were identified (see Table 1), which complicates comparisons among studies. Another problem is that few of these instruments were constructed and validated for IADL assessment in patients with MCI. The majority of the instruments used were originally designed for studies with patients with dementia, and thus the items are not calibrated to detect subtle differences from normal. Moreover, data on psychometric properties are mainly insufficient; for an overview of IADL scales in dementia where the need for validation studies is explicated, see the article by Sikkes et al. [83]. Measures specifically designed for MCI populations are required. This may be exemplified by the failure of the ADCS-ADL scale to reveal differences between patients with MCI and healthy controls [25], whereas the ADCS-MCI-ADL scales definitely detected differences [46,47]. The problem could be solved by constructing more sensitive item scoring for MCI-specific scales and/or by investigating in detail only those domains that have been shown to be impaired consistently in MCI, such as financial capacity. When the domain of financial capacity was thoroughly analyzed by an interview or a performance-based assessment procedure, differences between patients with MCI and control participants with cognitive impairment were persistently observed [26,32,39] and invariably revealed large effect sizes.
Furthermore, the majority of assessment instruments do not investigate computer skills or the handling of “new” technology in general. The instruments targeting ET use are examples of scales that focus on a particular domain that proved to be sensitive to subtle impairment, and significant differences were detected through both self-reports and observations [53-56].
Performance-based assessment methods seem to be a promising tool, especially for patients without proxies to provide information about the patient’s IADL. Moreover, performance-based methods would overcome another methodological issue related to self- and/or informant-report measures. In three reviewed studies [15,25,44], healthy controls rated their IADL capacity themselves, whereas MCI subjects were rated by their proxies. This inconsistency could lead to biased results, as rating procedures differed. All assessment methods have their limitations. When using self-report, patients tend to over- or underestimate their abilities and may not have full insight into the impairments caused by the disease. Informant-based methods rely on the informant’s knowledge about the patient, which might be affected by the amount of care provided. In addition, family members tend to misjudge the patient’s capacity. Performance-based instruments also have limitations, such as a higher degree of training needed by assessors, a more time-consuming evaluation and an unfamiliar environment that might bias the functional performance [84].
Furthermore, this review revealed some main problems of MCI definition. The operationalization of MCI is not clearly specified, which leads researchers to define cutoff points and choose assessment instruments of their own. The new criteria for prodromal AD/MCI due to AD may overcome this problem by including biomarkers for the diagnosis of the condition [85]. Nevertheless, the differentiation between MCI and dementia, as described in the new National Institute on Aging and Alzheimer’s Association criteria, rests on the determination of whether there is significant interference in the ability to function at work or in usual daily activities [86]. Therefore, the identification of IADL deficits in MCI as an early phase of AD is absolutely essential for clinical practice. Regarding the effect sizes, the differences between MCI subjects and healthy controls are not only statistically significant but also clinically relevant and can be considered quite robust. Defining a threshold of functional impairment, however, remains a difficult task. MCI is primarily a neuropsychologically defined construct. To give recommendations on exact thresholds, IADL measures which are specifically designed for and/or validated in MCI populations are needed first. If this is achieved, future criteria for MCI could postulate mild deficits in IADL functioning (that is, more than 1.5 standard deviations below healthy controls) in at least one of the following domains: financial abilities, keeping appointments, task completion time, task accuracy or remembering recent events.
It appears evident on the basis of this review that patients with MCI with IADL deficits are more likely to convert to dementia than are patients with MCI without IADL restrictions [27,32]. In fact, the presence of acquired IADL disability not due to a concomitant physical condition seems to be in itself a valid marker of prodromal AD. Studies assessing structural brain functioning and IADL impairment in MCI simultaneously [87] can help to identify relevant biomarkers of IADL deficits and at-risk individuals. Failure to detect an individual’s functional impairments might preclude training of these activities by occupational therapy or lead to neglecting needs and providing an inadequate amount of care from community-based services. Deterioration in IADL abilities, rather than cognition impairments, predicted a greater need of home help services in AD [88].

Conclusions

Although there was no uniform agreement about which IADL domains are typically—that is, characteristically and/or specifically—impaired in MCI and which types of instruments may detect those best, a clear tendency nevertheless emerged, with activities requiring higher cognitive processes being consistently affected. Also, the use of performance-based measures and technology-related items seems to be promising.
Future research should concentrate on both the thorough validation of established instruments and the development of new ones. As new instruments for IADL functioning in MCI are being developed, researchers should include items measuring the domains of financial capacities, keeping appointments, task completion time and task accuracy. Moreover, studies comparing the three assessment modalities—that is, self-report, informant-report rating and performance-based—in the same sample are needed. In the long run, this could lead to a more precise definition of functional impairment in MCI in terms of quantifiable cutoff scores.

Acknowledgements

KJ received a scholarship from the Robert-Bosch Stiftung, Germany. MEw is supported by the European Commission Marie Curie Training Grant (PCIG12-GA-2012-334259) and the LMUexcellent Investment Fund. FP thanks LabEx DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer’s disease) for their support. The work of SAMS is part of a fellowship project of Alzheimer Nederland, WE.15-2012-02. CW is currently receiving an ALF young researcher grant from Region Skåne, Sweden.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KJ conducted the literature search with support from MD, LH and LF and wrote the first draft of the manuscript. MEr, FP and LN added and analyzed literature regarding technology use. PJC, KP, EL and SAMS provided valuable input for restructuring parts of the manuscript. CW, RB, BD, MEw, EG, MGK, PM, JLM, MGMOR, JMO, ES, TS, RS, MT and BW were involved in revising the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–92.CrossRefPubMed Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–92.CrossRefPubMed
2.
Zurück zum Zitat Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.CrossRefPubMed Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.CrossRefPubMed
3.
Zurück zum Zitat Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–94. doi:10.1111/j.1365-2796.2004.01388.x.CrossRefPubMed Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183–94. doi:10.1111/j.1365-2796.2004.01388.x.CrossRefPubMed
4.
Zurück zum Zitat Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000;355:225–8. doi:10.1016/S0140-6736(99)06155-3.CrossRefPubMed Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000;355:225–8. doi:10.1016/S0140-6736(99)06155-3.CrossRefPubMed
5.
Zurück zum Zitat Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.CrossRefPubMed Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.CrossRefPubMed
6.
Zurück zum Zitat Albert SM, Michaels K, Padilla M, Pelton G, Bell K, Marder K, et al. Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry. 1999;7:213–20.CrossRefPubMed Albert SM, Michaels K, Padilla M, Pelton G, Bell K, Marder K, et al. Functional significance of mild cognitive impairment in elderly patients without a dementia diagnosis. Am J Geriatr Psychiatry. 1999;7:213–20.CrossRefPubMed
7.
Zurück zum Zitat Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58:758–64.CrossRefPubMed Tabert MH, Albert SM, Borukhova-Milov L, Camacho Y, Pelton G, Liu X, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 2002;58:758–64.CrossRefPubMed
8.
Zurück zum Zitat Okonkwo OC, Wadley VG, Griffith HR, Belue K, Lanza S, Zamrini EY, et al. Awareness of deficits in financial abilities in patients with mild cognitive impairment: going beyond self-informant discrepancy. Am J Geriatr Psychiatry. 2008;16:650–9. doi:10.1097/JGP.0b013e31817e8a9d.CrossRefPubMedCentralPubMed Okonkwo OC, Wadley VG, Griffith HR, Belue K, Lanza S, Zamrini EY, et al. Awareness of deficits in financial abilities in patients with mild cognitive impairment: going beyond self-informant discrepancy. Am J Geriatr Psychiatry. 2008;16:650–9. doi:10.1097/JGP.0b013e31817e8a9d.CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Farias ST, Mungas D, Jagust W. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int J Geriatr Psychiatry. 2005;20:827–34. doi:10.1002/gps.1367.CrossRefPubMedCentralPubMed Farias ST, Mungas D, Jagust W. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int J Geriatr Psychiatry. 2005;20:827–34. doi:10.1002/gps.1367.CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat DeBettignies BH, Mahurin RK, Pirozzolo FJ. Insight for impairment in independent living skills in Alzheimer’s disease and multi-infarct dementia. J Clin Exp Neuropsychol. 1990;12:355–63. doi:10.1080/01688639008400980.CrossRefPubMed DeBettignies BH, Mahurin RK, Pirozzolo FJ. Insight for impairment in independent living skills in Alzheimer’s disease and multi-infarct dementia. J Clin Exp Neuropsychol. 1990;12:355–63. doi:10.1080/01688639008400980.CrossRefPubMed
11.
Zurück zum Zitat Zanetti O, Geroldi C, Frisoni GB, Bianchetti A, Trabucchi M. Contrasting results between caregiver’s report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver’s personal characteristics. J Am Geriatr Soc. 1999;47:196–202.PubMed Zanetti O, Geroldi C, Frisoni GB, Bianchetti A, Trabucchi M. Contrasting results between caregiver’s report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver’s personal characteristics. J Am Geriatr Soc. 1999;47:196–202.PubMed
12.
Zurück zum Zitat Njegovan V, Man-Son-Hing M, Mitchell SL, Molnar FJ. The hierarchy of functional loss associated with cognitive decline in older persons. J Gerontol A Biol Sci Med Sci. 2001;56:M638–43. doi:10.1093/gerona/56.10.M638.CrossRefPubMed Njegovan V, Man-Son-Hing M, Mitchell SL, Molnar FJ. The hierarchy of functional loss associated with cognitive decline in older persons. J Gerontol A Biol Sci Med Sci. 2001;56:M638–43. doi:10.1093/gerona/56.10.M638.CrossRefPubMed
13.
Zurück zum Zitat Agüero-Torres H, Thomas Versus, Winblad B, Fratiglioni L. The impact of somatic and cognitive disorders on the functional status of the elderly. J Clin Epidemiol. 2002;55:1007–12.CrossRefPubMed Agüero-Torres H, Thomas Versus, Winblad B, Fratiglioni L. The impact of somatic and cognitive disorders on the functional status of the elderly. J Clin Epidemiol. 2002;55:1007–12.CrossRefPubMed
14.
Zurück zum Zitat Amieva H, Le Goff M, Millet X, Orgogozo JM, Pérès K, Barberger-Gateau P, et al. Prodromal Alzheimer’s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64:492–8. doi:10.1002/ana.21509.CrossRefPubMed Amieva H, Le Goff M, Millet X, Orgogozo JM, Pérès K, Barberger-Gateau P, et al. Prodromal Alzheimer’s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64:492–8. doi:10.1002/ana.21509.CrossRefPubMed
15.
Zurück zum Zitat Brown PJ, Devanand DP, Liu X, Caccappolo E, Alzheimer’s Disease Neuroimaging Initiative. Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry. 2011;68:617–26. doi:10.1001/archgenpsychiatry.2011.57.CrossRefPubMedCentralPubMed Brown PJ, Devanand DP, Liu X, Caccappolo E, Alzheimer’s Disease Neuroimaging Initiative. Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. Arch Gen Psychiatry. 2011;68:617–26. doi:10.1001/archgenpsychiatry.2011.57.CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Pérès K, Helmer C, Amieva H, Orgogozo JM, Rouch I, Dartigues JF, et al. Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study. J Am Geriatr Soc. 2008;56:37–44. doi:10.1111/j.1532-5415.2007.01499.x.CrossRefPubMed Pérès K, Helmer C, Amieva H, Orgogozo JM, Rouch I, Dartigues JF, et al. Natural history of decline in instrumental activities of daily living performance over the 10 years preceding the clinical diagnosis of dementia: a prospective population-based study. J Am Geriatr Soc. 2008;56:37–44. doi:10.1111/j.1532-5415.2007.01499.x.CrossRefPubMed
17.
Zurück zum Zitat Nygård L. Instrumental activities of daily living: a stepping-stone towards Alzheimer’s disease diagnosis in subjects with mild cognitive impairment? Acta Neurol Scand Suppl. 2003;179:42–6.CrossRefPubMed Nygård L. Instrumental activities of daily living: a stepping-stone towards Alzheimer’s disease diagnosis in subjects with mild cognitive impairment? Acta Neurol Scand Suppl. 2003;179:42–6.CrossRefPubMed
18.
Zurück zum Zitat Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–6.CrossRefPubMed Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240–6.CrossRefPubMed
19.
Zurück zum Zitat Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly: results from the Canadian Study of Health and Aging. Arch Neurol. 1995;52:612–9. doi:10.1001/archneur.1995.00540300086018.CrossRefPubMed Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly: results from the Canadian Study of Health and Aging. Arch Neurol. 1995;52:612–9. doi:10.1001/archneur.1995.00540300086018.CrossRefPubMed
20.
Zurück zum Zitat Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793–6.CrossRefPubMed Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793–6.CrossRefPubMed
21.
Zurück zum Zitat Levy R. Aging-associated cognitive decline: Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr. 1994;6:63–8.CrossRefPubMed Levy R. Aging-associated cognitive decline: Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr. 1994;6:63–8.CrossRefPubMed
22.
Zurück zum Zitat Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change—report of a National Institute of Mental Health work group. Dev Neuropsychol. 1986;2:261–76. doi:10.1080/87565648609540348.CrossRef Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change—report of a National Institute of Mental Health work group. Dev Neuropsychol. 1986;2:261–76. doi:10.1080/87565648609540348.CrossRef
23.
Zurück zum Zitat Aretouli E, Brandt J. Everyday functioning in mild cognitive impairment and its relationship with executive cognition. Int J Geriatr Psychiatry. 2010;25:224–33. doi:10.1002/gps.2325.CrossRefPubMedCentralPubMed Aretouli E, Brandt J. Everyday functioning in mild cognitive impairment and its relationship with executive cognition. Int J Geriatr Psychiatry. 2010;25:224–33. doi:10.1002/gps.2325.CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Giovannetti T, Bettcher BM, Brennan L, Libon DJ, Burke M, Duey K, et al. Characterization of everyday functioning in mild cognitive impairment: a direct assessment approach. Dement Geriatr Cogn Disord. 2008;25:359–65. doi:10.1159/000121005.CrossRefPubMed Giovannetti T, Bettcher BM, Brennan L, Libon DJ, Burke M, Duey K, et al. Characterization of everyday functioning in mild cognitive impairment: a direct assessment approach. Dement Geriatr Cogn Disord. 2008;25:359–65. doi:10.1159/000121005.CrossRefPubMed
25.
Zurück zum Zitat Goldberg TE, Koppel J, Keehlisen L, Christen E, Dreses-Werringloer U, Conejero-Goldberg C, et al. Performance-based measures of everyday function in mild cognitive impairment. Am J Psychiatry. 2010;167:845–53. doi:10.1176/appi.ajp.2010.09050692.CrossRefPubMedCentralPubMed Goldberg TE, Koppel J, Keehlisen L, Christen E, Dreses-Werringloer U, Conejero-Goldberg C, et al. Performance-based measures of everyday function in mild cognitive impairment. Am J Psychiatry. 2010;167:845–53. doi:10.1176/appi.ajp.2010.09050692.CrossRefPubMedCentralPubMed
26.
Zurück zum Zitat Griffith HR, Belue K, Sicola A, Krzywanski S, Zamrini E, Harrell L, et al. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology. 2003;60:449–57.CrossRefPubMed Griffith HR, Belue K, Sicola A, Krzywanski S, Zamrini E, Harrell L, et al. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology. 2003;60:449–57.CrossRefPubMed
27.
Zurück zum Zitat Peres K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P. Restriction in complex activities of daily living in MCI: impact on outcome. Neurology. 2006;67:461–6.CrossRefPubMed Peres K, Chrysostome V, Fabrigoule C, Orgogozo JM, Dartigues JF, Barberger-Gateau P. Restriction in complex activities of daily living in MCI: impact on outcome. Neurology. 2006;67:461–6.CrossRefPubMed
28.
Zurück zum Zitat Reppermund S, Brodaty H, Crawford JD, Kochan NA, Draper B, Slavin MJ, et al. Impairment in instrumental activities of daily living with high cognitive demand is an early marker of mild cognitive impairment: the Sydney Memory and Ageing Study. Psychol Med. 2013;43:2437–45. doi:10.1017/s003329171200308x.CrossRefPubMed Reppermund S, Brodaty H, Crawford JD, Kochan NA, Draper B, Slavin MJ, et al. Impairment in instrumental activities of daily living with high cognitive demand is an early marker of mild cognitive impairment: the Sydney Memory and Ageing Study. Psychol Med. 2013;43:2437–45. doi:10.1017/s003329171200308x.CrossRefPubMed
29.
Zurück zum Zitat Reppermund S, Sachdev PS, Crawford J, Kochan NA, Slavin MJ, Kang K, et al. The relationship of neuropsychological function to instrumental activities of daily living in mild cognitive impairment. Int J Geriatr Psychiatry. 2011;26:843–52. doi:10.1002/gps.2612.CrossRefPubMed Reppermund S, Sachdev PS, Crawford J, Kochan NA, Slavin MJ, Kang K, et al. The relationship of neuropsychological function to instrumental activities of daily living in mild cognitive impairment. Int J Geriatr Psychiatry. 2011;26:843–52. doi:10.1002/gps.2612.CrossRefPubMed
30.
Zurück zum Zitat Sherod MG, Griffith HR, Copeland J, Belue K, Krzywanski S, Zamrini EY, et al. Neurocognitive predictors of financial capacity across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer’s disease. J Int Neuropsychol Soc. 2009;15:258–67. doi:10.1017/S1355617709090365.CrossRefPubMedCentralPubMed Sherod MG, Griffith HR, Copeland J, Belue K, Krzywanski S, Zamrini EY, et al. Neurocognitive predictors of financial capacity across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer’s disease. J Int Neuropsychol Soc. 2009;15:258–67. doi:10.1017/S1355617709090365.CrossRefPubMedCentralPubMed
31.
Zurück zum Zitat Teng E, Becker BW, Woo E, Cummings JL, Lu PH. Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;30:189–97. doi:10.1159/000313540.CrossRefPubMedCentralPubMed Teng E, Becker BW, Woo E, Cummings JL, Lu PH. Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2010;30:189–97. doi:10.1159/000313540.CrossRefPubMedCentralPubMed
32.
Zurück zum Zitat Triebel KL, Martin R, Griffith HR, Marceaux J, Okonkwo OC, Harrell L, et al. Declining financial capacity in mild cognitive impairment: a 1-year longitudinal study. Neurology. 2009;73:928–34. doi:10.1212/WNL.0b013e3181b87971.CrossRefPubMedCentralPubMed Triebel KL, Martin R, Griffith HR, Marceaux J, Okonkwo OC, Harrell L, et al. Declining financial capacity in mild cognitive impairment: a 1-year longitudinal study. Neurology. 2009;73:928–34. doi:10.1212/WNL.0b013e3181b87971.CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat Yeh YC, Lin KN, Chen WT, Lin CY, Chen TB, Wang PN. Functional disability profiles in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 2011;31:225–32. doi:10.1159/000326910.CrossRefPubMed Yeh YC, Lin KN, Chen WT, Lin CY, Chen TB, Wang PN. Functional disability profiles in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 2011;31:225–32. doi:10.1159/000326910.CrossRefPubMed
34.
Zurück zum Zitat Schmitter-Edgecombe M, McAlister C, Weakley A. Naturalistic assessment of everyday functioning in individuals with mild cognitive impairment: the day-out task. Neuropsychology. 2012;26:631–41. doi:10.1037/a0029352.CrossRefPubMedCentralPubMed Schmitter-Edgecombe M, McAlister C, Weakley A. Naturalistic assessment of everyday functioning in individuals with mild cognitive impairment: the day-out task. Neuropsychology. 2012;26:631–41. doi:10.1037/a0029352.CrossRefPubMedCentralPubMed
35.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98. doi:10.1016/0022-3956(75)90026-6.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98. doi:10.1016/0022-3956(75)90026-6.CrossRefPubMed
36.
Zurück zum Zitat Kim KR, Lee KS, Cheong HK, Eom JS, Oh BH, Hong CH. Characteristic profiles of instrumental activities of daily living in different subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2009;27:278–85. doi:10.1159/000204765.CrossRefPubMed Kim KR, Lee KS, Cheong HK, Eom JS, Oh BH, Hong CH. Characteristic profiles of instrumental activities of daily living in different subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2009;27:278–85. doi:10.1159/000204765.CrossRefPubMed
37.
Zurück zum Zitat Burton CL, Strauss E, Bunce D, Hunter MA, Hultsch DF. Functional abilities in older adults with mild cognitive impairment. Gerontology. 2009;55:570–81. doi:10.1159/000228918.CrossRefPubMed Burton CL, Strauss E, Bunce D, Hunter MA, Hultsch DF. Functional abilities in older adults with mild cognitive impairment. Gerontology. 2009;55:570–81. doi:10.1159/000228918.CrossRefPubMed
38.
Zurück zum Zitat Malinowsky C, Almkvist O, Nygård L, Kottorp A. Individual variability and environmental characteristics influence older adults’ abilities to manage everyday technology. Int Psychogeriatr. 2012;24:484–95. doi:10.1017/S1041610211002092.CrossRefPubMed Malinowsky C, Almkvist O, Nygård L, Kottorp A. Individual variability and environmental characteristics influence older adults’ abilities to manage everyday technology. Int Psychogeriatr. 2012;24:484–95. doi:10.1017/S1041610211002092.CrossRefPubMed
39.
Zurück zum Zitat Marson DC, Martin RC, Wadley V, Griffith HR, Snyder S, Goode PS, et al. Clinical interview assessment of financial capacity in older adults with mild cognitive impairment and Alzheimer’s disease. J Am Geriatr Soc. 2009;57:806–14. doi:10.1111/j.1532-5415.2009.02202.x.CrossRefPubMedCentralPubMed Marson DC, Martin RC, Wadley V, Griffith HR, Snyder S, Goode PS, et al. Clinical interview assessment of financial capacity in older adults with mild cognitive impairment and Alzheimer’s disease. J Am Geriatr Soc. 2009;57:806–14. doi:10.1111/j.1532-5415.2009.02202.x.CrossRefPubMedCentralPubMed
40.
Zurück zum Zitat de Rotrou J, Wu YH, Hugonot-Diener L, Thomas-Antérion C, Vidal JS, Plichart M, et al. DAD-6: a 6-item version of the Disability Assessment for Dementia scale which may differentiate Alzheimer’s disease and mild cognitive impairment from controls. Dement Geriatr Cogn Disord. 2012;33:210–8. doi:10.1159/000338232.CrossRefPubMed de Rotrou J, Wu YH, Hugonot-Diener L, Thomas-Antérion C, Vidal JS, Plichart M, et al. DAD-6: a 6-item version of the Disability Assessment for Dementia scale which may differentiate Alzheimer’s disease and mild cognitive impairment from controls. Dement Geriatr Cogn Disord. 2012;33:210–8. doi:10.1159/000338232.CrossRefPubMed
41.
Zurück zum Zitat Ahn IS, Kim JH, Kim S, Chung JW, Kim H, Kang HS, et al. Impairment of instrumental activities of daily living in patients with mild cognitive impairment. Psychiatry Investig. 2009;6:180–4. doi:10.4306/pi.2009.6.3.180.CrossRefPubMedCentralPubMed Ahn IS, Kim JH, Kim S, Chung JW, Kim H, Kang HS, et al. Impairment of instrumental activities of daily living in patients with mild cognitive impairment. Psychiatry Investig. 2009;6:180–4. doi:10.4306/pi.2009.6.3.180.CrossRefPubMedCentralPubMed
42.
Zurück zum Zitat Boeve B, McCormick J, Smith G, Ferman T, Rummans T, Carpenter T, et al. Mild cognitive impairment in the oldest old. Neurology. 2003;60:477–80.CrossRefPubMed Boeve B, McCormick J, Smith G, Ferman T, Rummans T, Carpenter T, et al. Mild cognitive impairment in the oldest old. Neurology. 2003;60:477–80.CrossRefPubMed
43.
Zurück zum Zitat Jefferson AL, Byerly LK, Vanderhill S, Lambe S, Wong S, Ozonoff A, et al. Characterization of activities of daily living in individuals with mild cognitive impairment. Am J Geriatr Psychiatry. 2008;16:375–83.CrossRefPubMedCentralPubMed Jefferson AL, Byerly LK, Vanderhill S, Lambe S, Wong S, Ozonoff A, et al. Characterization of activities of daily living in individuals with mild cognitive impairment. Am J Geriatr Psychiatry. 2008;16:375–83.CrossRefPubMedCentralPubMed
44.
Zurück zum Zitat Mariani E, Monastero R, Ercolani S, Rinaldi P, Mangialasche F, Costanzi E, et al. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAI Project. Int J Geriatr Psychiatry. 2008;23:523–30. doi:10.1002/gps.1932.CrossRefPubMed Mariani E, Monastero R, Ercolani S, Rinaldi P, Mangialasche F, Costanzi E, et al. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAI Project. Int J Geriatr Psychiatry. 2008;23:523–30. doi:10.1002/gps.1932.CrossRefPubMed
45.
Zurück zum Zitat Pedrosa H, De Sa A, Guerreiro M, Marôco J, Simões MR, Galasko D, et al. Functional evaluation distinguishes MCI patients from healthy elderly people—the ADCS/MCI/ADL scale. J Nutr Health Aging. 2010;14:703–9.CrossRefPubMed Pedrosa H, De Sa A, Guerreiro M, Marôco J, Simões MR, Galasko D, et al. Functional evaluation distinguishes MCI patients from healthy elderly people—the ADCS/MCI/ADL scale. J Nutr Health Aging. 2010;14:703–9.CrossRefPubMed
46.
Zurück zum Zitat Perneczky R, Pohl C, Sorg C, Hartmann J, Komossa K, Alexopoulos P, et al. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues. Age Ageing. 2006;35:240–5. doi:10.1109/ageing/afj054.CrossRefPubMed Perneczky R, Pohl C, Sorg C, Hartmann J, Komossa K, Alexopoulos P, et al. Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues. Age Ageing. 2006;35:240–5. doi:10.1109/ageing/afj054.CrossRefPubMed
47.
Zurück zum Zitat Perneczky R, Pohl C, Sorg C, Hartmann J, Tosic N, Grimmer T, et al. Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry. 2006;21:158–62. doi:10.1002/gps.1444.CrossRefPubMed Perneczky R, Pohl C, Sorg C, Hartmann J, Tosic N, Grimmer T, et al. Impairment of activities of daily living requiring memory or complex reasoning as part of the MCI syndrome. Int J Geriatr Psychiatry. 2006;21:158–62. doi:10.1002/gps.1444.CrossRefPubMed
48.
Zurück zum Zitat Tam CW, Lam LC, Chiu HF, Lui VW. Characteristic profiles of instrumental activities of daily living in Chinese older persons with mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2007;22:211–7. doi:10.1177/1533317507301597.CrossRefPubMed Tam CW, Lam LC, Chiu HF, Lui VW. Characteristic profiles of instrumental activities of daily living in Chinese older persons with mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2007;22:211–7. doi:10.1177/1533317507301597.CrossRefPubMed
49.
Zurück zum Zitat Teng E, Becker BW, Woo E, Knopman DS, Cummings JL, Lu PH. Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010;24:348–53. doi:10.1097/WAD.0b013e3181e2fc84.CrossRefPubMedCentralPubMed Teng E, Becker BW, Woo E, Knopman DS, Cummings JL, Lu PH. Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord. 2010;24:348–53. doi:10.1097/WAD.0b013e3181e2fc84.CrossRefPubMedCentralPubMed
50.
Zurück zum Zitat Wadley VG, Okonkwo O, Crowe M, Ross-Meadows LA. Mild cognitive impairment and everyday function: evidence of reduced speed in performing instrumental activities of daily living. Am J Geriatr Psychiatry. 2008;16:416–24. doi:10.1097/JGP.0b013e31816b7303.CrossRefPubMed Wadley VG, Okonkwo O, Crowe M, Ross-Meadows LA. Mild cognitive impairment and everyday function: evidence of reduced speed in performing instrumental activities of daily living. Am J Geriatr Psychiatry. 2008;16:416–24. doi:10.1097/JGP.0b013e31816b7303.CrossRefPubMed
51.
Zurück zum Zitat Wadley VG, Okonkwo O, Crowe M, Vance DE, Elgin JM, Ball KK, et al. Mild cognitive impairment and everyday function: an investigation of driving performance. J Geriatr Psychiatry Neurol. 2009;22:87–94. doi:10.1177/0891988708328215.CrossRefPubMedCentralPubMed Wadley VG, Okonkwo O, Crowe M, Vance DE, Elgin JM, Ball KK, et al. Mild cognitive impairment and everyday function: an investigation of driving performance. J Geriatr Psychiatry Neurol. 2009;22:87–94. doi:10.1177/0891988708328215.CrossRefPubMedCentralPubMed
52.
Zurück zum Zitat Werner P, Rabinowitz S, Klinger E, Korczyn AD, Josman N. Use of the virtual action planning supermarket for the diagnosis of mild cognitive impairment: a preliminary study. Dement Geriatr Cogn Disord. 2009;27:301–9. doi:10.1159/000204915.CrossRefPubMed Werner P, Rabinowitz S, Klinger E, Korczyn AD, Josman N. Use of the virtual action planning supermarket for the diagnosis of mild cognitive impairment: a preliminary study. Dement Geriatr Cogn Disord. 2009;27:301–9. doi:10.1159/000204915.CrossRefPubMed
53.
Zurück zum Zitat Malinowsky C, Almkvist O, Kottorp A, Nygård L. Ability to manage everyday technology: a comparison of persons with dementia or mild cognitive impairment and older adults without cognitive impairment. Disabil Rehabil Assist Technol. 2010;5:462–9. doi:10.3109/17483107.2010.496098.CrossRefPubMed Malinowsky C, Almkvist O, Kottorp A, Nygård L. Ability to manage everyday technology: a comparison of persons with dementia or mild cognitive impairment and older adults without cognitive impairment. Disabil Rehabil Assist Technol. 2010;5:462–9. doi:10.3109/17483107.2010.496098.CrossRefPubMed
54.
Zurück zum Zitat Muñoz-Neira C, López OL, Riveros R, Núñez-Huasaf J, Flores P, Slachevsky A. The Technology–Activities of Daily Living Questionnaire: a version with a technology-related subscale. Dement Geriatr Cogn Disord. 2012;33:361–71. doi:10.1159/000338606.CrossRefPubMed Muñoz-Neira C, López OL, Riveros R, Núñez-Huasaf J, Flores P, Slachevsky A. The Technology–Activities of Daily Living Questionnaire: a version with a technology-related subscale. Dement Geriatr Cogn Disord. 2012;33:361–71. doi:10.1159/000338606.CrossRefPubMed
55.
Zurück zum Zitat Nygård L, Pantzar M, Uppgard B, Kottorp A. Detection of activity limitations in older adults with MCI or Alzheimer’s disease through evaluation of perceived difficulty in use of everyday technology: a replication study. Aging Ment Health. 2012;16:361–71. doi:10.1080/13607863.2011.605055.CrossRefPubMed Nygård L, Pantzar M, Uppgard B, Kottorp A. Detection of activity limitations in older adults with MCI or Alzheimer’s disease through evaluation of perceived difficulty in use of everyday technology: a replication study. Aging Ment Health. 2012;16:361–71. doi:10.1080/13607863.2011.605055.CrossRefPubMed
56.
Zurück zum Zitat Rosenberg L, Kottorp A, Winblad B, Nygård L. Perceived difficulty in everyday technology use among older adults with or without cognitive deficits. Scand J Occup Ther. 2009;16:216–26. doi:10.3109/11038120802684299.CrossRefPubMed Rosenberg L, Kottorp A, Winblad B, Nygård L. Perceived difficulty in everyday technology use among older adults with or without cognitive deficits. Scand J Occup Ther. 2009;16:216–26. doi:10.3109/11038120802684299.CrossRefPubMed
57.
Zurück zum Zitat Binegar DL, Hynan LS, Lacritz LH, Weiner MF, Cullum CM. Can a direct IADL measure detect deficits in persons with MCI? Curr Alzheimer Res. 2009;6:48–51.CrossRefPubMedCentralPubMed Binegar DL, Hynan LS, Lacritz LH, Weiner MF, Cullum CM. Can a direct IADL measure detect deficits in persons with MCI? Curr Alzheimer Res. 2009;6:48–51.CrossRefPubMedCentralPubMed
58.
Zurück zum Zitat Luck T, Luppa M, Angermeyer MC, Villringer A, König HH, Riedel-Heller SG. Impact of impairment in instrumental activities of daily living and mild cognitive impairment on time to incident dementia: results of the Leipzig Longitudinal Study of the Aged. Psychol Med. 2011;41:1087–97. doi:10.1017/S003329171000142X.CrossRefPubMed Luck T, Luppa M, Angermeyer MC, Villringer A, König HH, Riedel-Heller SG. Impact of impairment in instrumental activities of daily living and mild cognitive impairment on time to incident dementia: results of the Leipzig Longitudinal Study of the Aged. Psychol Med. 2011;41:1087–97. doi:10.1017/S003329171000142X.CrossRefPubMed
59.
Zurück zum Zitat O’Connor ML, Edwards JD, Wadley VG, Crowe M. Changes in mobility among older adults with psychometrically defined mild cognitive impairment. J Gerontol B Psychol Sci Soc Sci. 2010;65B:306–16. doi:10.1093/geronb/gbq003.CrossRefPubMedCentralPubMed O’Connor ML, Edwards JD, Wadley VG, Crowe M. Changes in mobility among older adults with psychometrically defined mild cognitive impairment. J Gerontol B Psychol Sci Soc Sci. 2010;65B:306–16. doi:10.1093/geronb/gbq003.CrossRefPubMedCentralPubMed
60.
Zurück zum Zitat Pereira FS, Yassuda MS, Oliveira AM, Diniz BS, Radanovic M, Talib LL, et al. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuropsychol Soc. 2010;16:297–305. doi:10.1017/S1355617709991330.CrossRefPubMed Pereira FS, Yassuda MS, Oliveira AM, Diniz BS, Radanovic M, Talib LL, et al. Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement. J Int Neuropsychol Soc. 2010;16:297–305. doi:10.1017/S1355617709991330.CrossRefPubMed
61.
Zurück zum Zitat Wadley VG, Crowe M, Marsiske M, Cook SE, Unverzagt FW, Rosenberg AL, et al. Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly Study. J Am Geriatr Soc. 2007;55:1192–8. doi:10.1111/j.1532-5415.2007.01245.x.CrossRefPubMedCentralPubMed Wadley VG, Crowe M, Marsiske M, Cook SE, Unverzagt FW, Rosenberg AL, et al. Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly Study. J Am Geriatr Soc. 2007;55:1192–8. doi:10.1111/j.1532-5415.2007.01245.x.CrossRefPubMedCentralPubMed
62.
Zurück zum Zitat Loewenstein DA, Amigo E, Duara R, Guterman A, Hurwitz D, Berkowitz N, et al. A new scale for the assessment of functional status in Alzheimer’s disease and related disorders. J Gerontol. 1989;44:P114–21. doi:10.1093/geronj/44.4.P114.CrossRefPubMed Loewenstein DA, Amigo E, Duara R, Guterman A, Hurwitz D, Berkowitz N, et al. A new scale for the assessment of functional status in Alzheimer’s disease and related disorders. J Gerontol. 1989;44:P114–21. doi:10.1093/geronj/44.4.P114.CrossRefPubMed
63.
Zurück zum Zitat Willis S, Marsiske M. Manual for the Everyday Problems Test. University Park: Pennsylvania State University; 1993. Willis S, Marsiske M. Manual for the Everyday Problems Test. University Park: Pennsylvania State University; 1993.
64.
Zurück zum Zitat Marson DC, Sawrie SM, Snyder S, McInturff B, Stalvey T, Boothe A, et al. Assessing financial capacity in patients with Alzheimer disease: a conceptual model and prototype instrument. Arch Neurol. 2000;57:877–84. doi:10.1001/archneur.57.6.877.CrossRefPubMed Marson DC, Sawrie SM, Snyder S, McInturff B, Stalvey T, Boothe A, et al. Assessing financial capacity in patients with Alzheimer disease: a conceptual model and prototype instrument. Arch Neurol. 2000;57:877–84. doi:10.1001/archneur.57.6.877.CrossRefPubMed
65.
Zurück zum Zitat Cullum CM, Saine K, Chan LD, Martin-Cook K, Gray KF, Weiner MF. Performance-based instrument to assess functional capacity in dementia: the Texas Functional Living Scale. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:103–8.PubMed Cullum CM, Saine K, Chan LD, Martin-Cook K, Gray KF, Weiner MF. Performance-based instrument to assess functional capacity in dementia: the Texas Functional Living Scale. Neuropsychiatry Neuropsychol Behav Neurol. 2001;14:103–8.PubMed
66.
Zurück zum Zitat Owsley C, Sloane M, McGwin Jr G, Ball K. Timed instrumental activities of daily living tasks: relationship to cognitive function and everyday performance assessments in older adults. Gerontology. 2002;48:254–65.CrossRefPubMed Owsley C, Sloane M, McGwin Jr G, Ball K. Timed instrumental activities of daily living tasks: relationship to cognitive function and everyday performance assessments in older adults. Gerontology. 2002;48:254–65.CrossRefPubMed
67.
Zurück zum Zitat Bowers A, Peli E, Elgin J, McGwin Jr G, Owsley C. On-road driving with moderate visual field loss. Optom Vis Sci. 2005;82:657–67.CrossRefPubMed Bowers A, Peli E, Elgin J, McGwin Jr G, Owsley C. On-road driving with moderate visual field loss. Optom Vis Sci. 2005;82:657–67.CrossRefPubMed
68.
Zurück zum Zitat Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: Development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27:235–45.CrossRefPubMed Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: Development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull. 2001;27:235–45.CrossRefPubMed
69.
Zurück zum Zitat Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33–9.CrossRefPubMed Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease. Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33–9.CrossRefPubMed
70.
Zurück zum Zitat Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD, et al. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006;20(4 Suppl 3):S152–69.CrossRefPubMed Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD, et al. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006;20(4 Suppl 3):S152–69.CrossRefPubMed
71.
Zurück zum Zitat Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord. 1998;9 Suppl 2:20–6.CrossRefPubMed Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H. The Bayer Activities of Daily Living Scale (B-ADL). Dement Geriatr Cogn Disord. 1998;9 Suppl 2:20–6.CrossRefPubMed
72.
Zurück zum Zitat Gelinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia. Am J Occup Ther. 1999;53:471–81.CrossRefPubMed Gelinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer’s disease: the disability assessment for dementia. Am J Occup Ther. 1999;53:471–81.CrossRefPubMed
73.
Zurück zum Zitat Pfeffer RI, Kurosaki TT, Harrah Jr CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323–9.CrossRefPubMed Pfeffer RI, Kurosaki TT, Harrah Jr CH, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323–9.CrossRefPubMed
74.
Zurück zum Zitat Glosser G, Gallo J, Duda N, de Vries JJ, Clark CM, Grossman M. Visual perceptual functions predict instrumental activities of daily living in patients with dementia. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15:198–206.PubMed Glosser G, Gallo J, Duda N, de Vries JJ, Clark CM, Grossman M. Visual perceptual functions predict instrumental activities of daily living in patients with dementia. Neuropsychiatry Neuropsychol Behav Neurol. 2002;15:198–206.PubMed
75.
Zurück zum Zitat Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015–22. doi:10.1017/S0033291700005742.CrossRefPubMed Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015–22. doi:10.1017/S0033291700005742.CrossRefPubMed
76.
Zurück zum Zitat Weintraub S. The record of independent living: an informant-completed measure of activities of daily living and behavior in elderly patients with cognitive impairment. Am J Alzheimers Dis Other Demen. 1986;1:35–9. doi:10.1177/153331758600100210.CrossRef Weintraub S. The record of independent living: an informant-completed measure of activities of daily living and behavior in elderly patients with cognitive impairment. Am J Alzheimers Dis Other Demen. 1986;1:35–9. doi:10.1177/153331758600100210.CrossRef
77.
Zurück zum Zitat Morris JN, Fries BE, Steel K, Ikegami N, Bernabei R, Carpenter GI, et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc. 1997;45:1017–24.PubMed Morris JN, Fries BE, Steel K, Ikegami N, Bernabei R, Carpenter GI, et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J Am Geriatr Soc. 1997;45:1017–24.PubMed
78.
Zurück zum Zitat Ku H, Kim J, Lee H, Ko H, Kwon E, Jo S. A study on the reliability and validity of Seoul-Activities of Daily Living (S-ADL). J Korean Geriatr Soc. 2004;8:206–14. Ku H, Kim J, Lee H, Ko H, Kwon E, Jo S. A study on the reliability and validity of Seoul-Activities of Daily Living (S-ADL). J Korean Geriatr Soc. 2004;8:206–14.
79.
Zurück zum Zitat Bruininks R, Woodcock R, Weatherman R, Bradley B. Scales of Independent Behavior–Revised: comprehensive manual. Itasca, IL: Riverside; 1996. Bruininks R, Woodcock R, Weatherman R, Bradley B. Scales of Independent Behavior–Revised: comprehensive manual. Itasca, IL: Riverside; 1996.
80.
Zurück zum Zitat Schneekloth U, Potthoff P. Help and need of care of community dwelling elderly: results of the representative research project. Potentials and limitations of independent living. Stuttgart, Germany: Kohlhammer; 1993. German. Schneekloth U, Potthoff P. Help and need of care of community dwelling elderly: results of the representative research project. Potentials and limitations of independent living. Stuttgart, Germany: Kohlhammer; 1993. German.
81.
Zurück zum Zitat Wattmo C, Wallin AK, Minthon L. Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies. Alzheimers Res Ther. 2013;5:44. doi:10.1186/alzrt210.CrossRefPubMedCentralPubMed Wattmo C, Wallin AK, Minthon L. Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies. Alzheimers Res Ther. 2013;5:44. doi:10.1186/alzrt210.CrossRefPubMedCentralPubMed
82.
Zurück zum Zitat Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–9. doi:10.1212/01.WNL.0000034176.07159.F8.CrossRefPubMed Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–9. doi:10.1212/01.WNL.0000034176.07159.F8.CrossRefPubMed
83.
Zurück zum Zitat Sikkes SAM, de Lange-de Klerk ESM, Pijnenburg YAL, Scheltens P, Uitdehaag BMJ. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry. 2009;80:7–12. doi:10.1136/jnnp.2008.155838.CrossRefPubMed Sikkes SAM, de Lange-de Klerk ESM, Pijnenburg YAL, Scheltens P, Uitdehaag BMJ. A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry. 2009;80:7–12. doi:10.1136/jnnp.2008.155838.CrossRefPubMed
84.
Zurück zum Zitat Desai AK, Grossberg GT, Sheth DN. Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment. CNS Drugs. 2004;18:853–75.CrossRefPubMed Desai AK, Grossberg GT, Sheth DN. Activities of daily living in patients with dementia: clinical relevance, methods of assessment and effects of treatment. CNS Drugs. 2004;18:853–75.CrossRefPubMed
85.
Zurück zum Zitat Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9. doi:10.1016/j.jalz.2011.03.008.CrossRefPubMedCentralPubMed Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9. doi:10.1016/j.jalz.2011.03.008.CrossRefPubMedCentralPubMed
86.
Zurück zum Zitat McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9. doi:10.1016/j.jalz.2011.03.005.CrossRefPubMedCentralPubMed McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9. doi:10.1016/j.jalz.2011.03.005.CrossRefPubMedCentralPubMed
87.
Zurück zum Zitat Farias ST, Park LQ, Harvey DJ, Simon C, Reed BR, Carmichael O, et al. Everyday cognition in older adults: associations with neuropsychological performance and structural brain imaging. J Int Neuropsychol Soc. 2013;19:430–41. doi:10.1017/S1355617712001609.CrossRefPubMed Farias ST, Park LQ, Harvey DJ, Simon C, Reed BR, Carmichael O, et al. Everyday cognition in older adults: associations with neuropsychological performance and structural brain imaging. J Int Neuropsychol Soc. 2013;19:430–41. doi:10.1017/S1355617712001609.CrossRefPubMed
88.
Zurück zum Zitat Wattmo C, Paulsson E, Minthon L, Londos E. A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy. Clin Interv Aging. 2013;8:329–39. doi:10.2147/CIA.S40087.CrossRefPubMedCentralPubMed Wattmo C, Paulsson E, Minthon L, Londos E. A longitudinal study of risk factors for community-based home help services in Alzheimer’s disease: the influence of cholinesterase inhibitor therapy. Clin Interv Aging. 2013;8:329–39. doi:10.2147/CIA.S40087.CrossRefPubMedCentralPubMed
Metadaten
Titel
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review
verfasst von
Katrin Jekel
Marinella Damian
Carina Wattmo
Lucrezia Hausner
Roger Bullock
Peter J Connelly
Bruno Dubois
Maria Eriksdotter
Michael Ewers
Elmar Graessel
Milica G Kramberger
Emma Law
Patrizia Mecocci
José L Molinuevo
Louise Nygård
Marcel GM Olde-Rikkert
Jean-Marc Orgogozo
Florence Pasquier
Karine Peres
Eric Salmon
Sietske AM Sikkes
Tomasz Sobow
René Spiegel
Magda Tsolaki
Bengt Winblad
Lutz Frölich
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
Alzheimer's Research & Therapy / Ausgabe 1/2015
Elektronische ISSN: 1758-9193
DOI
https://doi.org/10.1186/s13195-015-0099-0

Weitere Artikel der Ausgabe 1/2015

Alzheimer's Research & Therapy 1/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.